TSS:Hg 179603.1

Basic information about the TSS

---

TSS ID: hg_179603.1 Species: human Chr: chr19		Start: 14090169 End: 14090227 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC030129 Distance: 159 GeneID: 90378 HGNC/MGI_ID: HGNC:17958 UniProt_ID:

Gene_name: sterile alpha motif domain containing 1 Gene_symbol: SAMD1 Gene_synonyms: Gene_source: HGNC:17958

TATA-Box annotation

---

Distance to TSS:	553
Nearest PromoterID:	NM_138352
Entrez ID:	90378
Nearest Unigene:	Hs.140309
Nearest Refseq:	NM_138352
Nearest Ensembl:	ENSG00000141858
Gene Name:	sterile alpha motif domain containing 1
Gene Alias:	-
Gene Description:	sterile alpha motif domain containing 1
Gene Type:	protein-coding
CpG%:	0.175
GC%:	0.761194
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SAMD1 p2@SAMD1 p3@SAMD1 p4@SAMD1 p5@SAMD1 p6@SAMD1 p7@SAMD1 p8@SAMD1
Sample		p1@SAMD1	p2@SAMD1	p3@SAMD1	p4@SAMD1	p5@SAMD1	p6@SAMD1	p7@SAMD1	p8@SAMD1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	6.04	11.10	1.56	0.39	3.51	0.97	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	5.66	11.33	3.24	1.21	3.03	0.81	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	6.56	9.84	1.74	0.58	3.67	0.58	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.99	6.65	2.70	0.83	3.33	1.04	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.27	7.42	1.12	0.90	3.82	0.67	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	4.65	5.43	0.97	0.19	3.10	0.78	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	6.32	9.15	2.18	1.31	2.61	1.31	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.75	7.51	4.12	0.24	3.39	0.73	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	8.33	5.77	2.78	0.64	2.14	1.71	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	1.16	2.32	0.58	0.58	1.74	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	1.62	4.04	0.40	0.00	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	2.03	1.63	1.22	0.00	0.00	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.76	9.67	4.35	3.55	0.97	1.29	2.58	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	16.84	6.92	2.56	2.26	0.90	1.65	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.05	8.56	1.98	3.07	1.10	2.42	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.83	11.82	3.77	2.26	0.50	1.76	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.94	7.43	2.40	2.40	0.22	1.31	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	17.29	11.39	4.22	2.11	0.00	1.69	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	10.66	10.13	2.13	1.07	0.53	1.60	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	12.64	10.38	2.71	1.81	0.30	0.90	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.70	8.42	4.14	3.47	0.53	1.07	1.20	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	19.16	9.49	3.45	2.76	1.04	1.04	1.55	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.44	8.53	2.97	1.42	0.39	1.55	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	18.20	8.25	3.88	2.67	0.49	1.94	0.97	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	18.06	8.77	4.13	3.35	0.52	2.06	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.39	19.94	4.43	3.17	0.95	2.22	1.58	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.88	9.34	2.20	1.65	0.00	0.55	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.75	9.43	6.84	4.24	1.65	2.36	1.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	18.90	10.66	4.85	3.23	1.29	2.10	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.72	9.77	4.52	3.26	1.99	1.81	2.17	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.63	11.93	3.35	1.67	0.42	1.05	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	19.93	15.24	2.34	1.56	1.76	2.34	2.15	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	17.30	11.18	2.95	2.32	0.84	1.69	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	11.55	9.90	4.12	1.15	1.15	1.48	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	17.95	7.29	3.55	3.55	1.87	2.24	1.68	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	20.31	8.43	6.52	4.60	1.53	1.92	1.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	19.62	10.63	3.68	3.07	1.23	1.23	2.04	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	16.72	9.47	3.22	3.02	1.21	2.42	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	14.05	5.94	2.97	2.97	1.62	1.35	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.56	9.60	2.40	2.88	1.20	1.20	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	11.06	9.88	2.12	2.35	2.35	1.65	1.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.13	10.69	3.07	1.90	1.46	1.32	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.34	10.33	4.01	4.01	1.27	1.05	1.90	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	14.86	9.09	5.24	1.57	2.62	1.22	0.87	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.66	6.02	4.42	3.41	3.01	2.81	1.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.33	8.14	5.12	2.79	1.16	2.79	2.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.67	8.40	5.04	2.16	1.20	3.60	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9.24	11.33	4.17	4.47	1.19	2.38	2.09	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.81	9.81	3.11	3.11	2.39	1.20	1.44	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	9.30	9.91	2.83	1.62	1.42	2.22	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.48	5.74	4.92	2.25	1.43	1.23	1.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.57	6.45	2.67	4.23	1.33	2.67	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	167.91	0.00	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.03	4.26	6.39	2.48	0.71	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	20.21	3.31	2.98	3.65	0.99	0.99	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	8.39	22.65	1.68	0.00	3.36	2.52	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.73	6.43	3.21	0.92	1.84	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.66	4.54	4.86	5.83	0.97	1.62	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	23.12	3.85	1.61	4.18	0.00	0.96	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.63	11.32	1.26	1.57	1.26	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	18.33	4.94	4.23	1.41	0.00	1.41	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.70	3.93	1.68	1.68	1.12	1.68	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.17	17.52	2.39	1.59	0.80	4.78	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	11.55	4.08	2.38	2.72	0.68	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.92	5.52	1.95	3.90	0.00	2.27	1.95	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.75	3.55	4.61	4.61	0.71	2.48	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	193.97	0.00	0.00	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	118.46	23.69	7.90	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.55	2.44	3.41	2.44	0.00	0.00	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	14.88	3.47	3.47	2.98	0.50	0.50	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	21.58	1.41	1.41	1.41	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.88	8.61	1.99	1.99	1.32	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	24.75	4.64	2.78	4.02	0.31	0.93	1.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	26.60	3.06	1.83	1.22	0.31	0.61	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	11.25	8.87	1.27	1.58	1.27	0.48	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	6.10	8.02	0.80	1.76	1.12	0.96	0.48	0.16
Adipocyte - omental, donor1	11473-119C6	12.09	6.49	0.89	1.65	1.40	0.89	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	10.46	1.49	0.75	1.49	2.99	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	6.36	1.67	0.67	1.00	2.34	2.01	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	3.19	0.64	0.64	0.00	0.64	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	1.10	2.20	1.10	0.00	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.03	8.58	1.35	1.35	1.81	0.90	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	6.95	7.12	1.39	2.43	0.70	1.04	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	10.76	9.19	2.15	1.56	0.98	0.59	1.17	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	4.63	3.86	0.26	0.51	0.77	1.03	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	4.18	4.18	0.28	1.39	0.00	0.56	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	4.11	5.29	1.18	1.76	0.59	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	11.34	11.02	1.77	2.01	4.42	1.05	1.05	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	5.49	3.87	0.65	0.00	0.97	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	2.67	2.67	0.53	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	3.90	2.23	0.56	0.00	2.23	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.07	4.16	0.83	2.50	3.33	0.83	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	5.02	5.53	1.00	2.01	1.51	0.75	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	4.58	4.91	0.65	1.64	1.64	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	5.78	4.26	0.30	0.61	2.74	0.61	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	15.47	8.40	2.21	2.43	1.77	1.55	0.66	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	34.78	5.38	5.02	2.87	5.02	1.43	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	20.37	11.98	0.00	1.20	1.20	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	7.20	5.76	1.62	1.62	0.72	0.54	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	8.37	0.00	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.16	9.25	1.85	1.03	0.00	0.41	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	6.52	6.41	1.03	0.92	0.11	0.00	0.57	0.00
Anulus Pulposus Cell, donor2	11463-119B5	3.67	1.71	1.22	0.73	1.22	0.24	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	3.59	4.49	1.80	0.90	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	2.17	3.04	0.43	0.43	0.00	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	0.00	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	2.99	3.59	0.30	0.00	0.00	0.90	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	3.79	0.00	0.00	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.92	3.30	0.00	0.00	1.32	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	2.92	2.27	1.30	0.32	0.00	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	3.88	2.91	0.00	0.00	0.00	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	1.78	0.59	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.14	1.88	0.00	0.75	0.00	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	2.90	4.35	0.00	0.73	1.45	3.63	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	2.51	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	1.98	4.45	1.15	0.66	0.16	0.33	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	2.73	0.00	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.48	2.87	0.60	1.06	0.15	0.15	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	2.68	2.68	1.07	0.00	0.54	1.07	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5.29	2.65	0.57	0.19	0.00	0.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.35	2.94	0.53	0.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	0.98	0.98	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	3.32	2.32	0.33	0.83	0.33	0.66	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	4.80	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	3.43	3.26	0.17	0.86	0.34	0.34	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.37	1.46	0.97	1.46	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.59	4.17	1.14	0.38	0.00	0.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	7.27	0.00	0.00	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	4.56	3.99	0.57	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.92	2.14	0.43	0.21	0.21	0.64	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.19	3.10	0.00	1.29	0.26	1.81	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	1.88	2.82	0.00	0.00	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	3.86	1.61	0.96	0.64	0.00	0.64	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	3.57	0.00	1.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	3.51	1.17	1.75	0.58	0.00	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.23	1.81	0.90	0.00	0.30	0.30	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	5.94	0.00	1.19	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.09	5.09	1.02	0.00	0.00	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	5.86	3.57	1.53	0.51	0.51	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	2.54	3.18	1.27	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.88	2.59	0.86	0.00	0.00	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.29	2.33	1.06	0.42	0.42	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.80	2.61	0.29	2.03	0.00	0.87	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	3.78	4.72	1.89	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	3.90	2.71	0.85	1.36	0.17	0.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	2.32	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	0.00	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.07	2.36	0.43	0.43	0.21	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	3.01	0.00	0.60	0.00	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	2.92	1.46	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.06	2.76	0.23	0.23	0.23	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	5.10	2.55	0.00	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3.05	1.02	0.00	0.76	0.25	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	3.72	1.45	0.62	0.62	0.62	0.62	0.62	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.51	2.45	0.92	0.92	0.31	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	1.43	1.91	1.43	0.00	0.48	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	3.99	1.77	0.67	0.67	0.44	0.22	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	4.58	3.05	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	2.22	3.88	0.00	0.00	0.55	1.11	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	2.65	2.38	1.06	0.26	0.26	0.79	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.36	2.18	1.09	0.36	0.00	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	17.32	3.32	3.81	1.35	2.46	0.74	0.49	0.00
Astrocyte - cerebellum, donor2	11580-120F5	15.06	3.77	3.59	2.91	1.20	0.17	1.54	0.00
Astrocyte - cerebellum, donor3	11661-122F5	10.91	10.28	3.36	0.63	0.63	0.84	1.05	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	10.46	6.97	2.79	0.70	0.70	0.70	2.09	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	10.68	12.29	3.24	1.29	0.65	1.29	1.13	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	13.13	8.20	4.18	2.39	1.19	0.60	1.79	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	20.99	16.74	1.26	1.83	1.49	1.26	0.92	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	19.92	19.04	2.88	1.38	1.88	1.25	0.50	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	17.87	15.13	1.37	1.25	1.48	1.59	0.34	0.00
Basophils, donor1	12241-129G9	2.35	1.57	0.00	1.57	1.57	0.78	0.00	0.00
Basophils, donor2	12242-129H1	8.30	3.25	0.36	1.08	0.72	0.36	0.00	0.00
Basophils, donor3	12243-129H2	8.08	6.32	0.15	0.59	1.47	0.00	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	11.00	6.47	1.29	1.29	1.72	0.86	0.65	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	33.83	6.40	2.29	1.83	6.40	0.91	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	19.46	2.51	0.63	1.26	0.63	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	17.26	3.54	2.29	3.12	1.87	0.62	0.62	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	11.74	2.76	0.46	1.38	0.23	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	11.70	7.56	1.08	1.08	1.44	0.18	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	33.70	32.87	2.78	5.05	7.01	1.13	0.93	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	41.22	21.43	2.10	4.89	4.66	1.16	0.70	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.98	12.15	2.56	5.12	0.00	0.64	2.24	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	6.20	5.07	0.00	1.13	1.13	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	3.16	3.53	0.00	0.93	1.30	0.00	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	5.93	2.85	0.22	1.54	1.10	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	11.04	11.04	1.42	1.42	1.13	0.57	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	18.20	10.99	0.38	1.14	0.38	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	14.46	9.86	0.66	2.63	1.64	0.33	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	2.75	2.75	0.00	0.14	0.58	0.14	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	2.72	2.41	0.00	0.00	1.21	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	5.45	3.08	0.47	0.95	1.18	0.47	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1.17	0.67	0.00	0.33	0.67	0.33	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.76	0.00	0.00	0.28	0.83	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.74	0.25	0.25	0.25	0.99	0.25	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.78	0.20	0.00	0.39	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.14	0.36	0.00	0.53	0.89	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.74	0.65	0.00	0.00	0.65	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.34	1.17	0.00	0.00	0.94	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.64	2.11	0.53	0.53	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3.33	2.22	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1.34	1.19	0.15	0.00	0.45	0.59	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.20	0.80	0.20	0.20	1.00	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.50	1.04	0.00	0.83	1.04	0.21	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1.14	0.92	0.00	0.00	0.69	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.04	0.45	0.23	0.00	0.68	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.44	0.87	0.00	0.44	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.54	0.54	0.00	0.27	0.81	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1.92	1.92	0.17	0.35	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	3.37	0.84	0.00	0.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.00	0.37	0.00	0.00	0.55	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.70	1.06	0.00	0.00	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.88	0.44	0.00	0.00	2.19	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.27	1.74	0.00	0.17	0.70	0.00	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.97	1.12	0.00	0.00	1.49	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2.80	0.43	0.00	0.22	0.43	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1.64	1.23	0.00	0.82	0.41	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.62	0.00	0.00	0.23	2.09	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.46	0.23	0.00	0.00	0.93	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	8.50	2.18	0.00	0.00	1.74	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	6.24	1.85	0.00	0.69	0.23	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	5.85	1.52	0.00	0.22	0.00	0.22	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	17.75	6.38	0.16	2.34	1.25	0.31	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	13.97	6.99	0.17	1.22	1.57	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	10.48	1.56	0.00	0.67	0.89	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	1.79	3.06	0.00	0.77	0.77	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.51	1.10	0.00	0.22	1.54	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	3.58	0.84	0.00	0.63	0.21	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	2.03	0.00	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4.75	8.14	0.00	0.00	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	1.04	0.00	1.04	0.00	0.00	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	5.33	1.60	0.53	1.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5.90	5.90	0.00	0.54	0.00	0.00	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4.21	1.40	0.70	2.11	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4.71	3.92	0.00	1.57	1.57	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	3.95	3.95	0.00	0.00	2.64	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	7.40	5.75	0.00	1.64	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	5.80	5.08	0.73	0.73	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	5.55	5.55	0.00	1.51	2.02	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	48.89	25.05	1.62	3.23	17.78	0.40	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	57.13	24.77	0.80	2.80	15.18	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	2.01	2.01	0.00	0.00	0.00	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	2.81	2.25	1.12	0.56	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	33.44	18.41	1.88	3.38	0.38	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	22.32	10.15	0.68	3.16	1.35	0.68	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	10.71	5.71	0.36	2.86	0.36	0.71	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	11.63	10.41	1.22	2.45	0.00	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	11.89	9.15	0.91	1.83	0.30	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	23.23	15.82	1.28	1.28	1.02	0.51	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	49.64	22.68	0.22	3.59	1.12	0.00	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	43.69	20.70	1.44	3.16	0.57	0.29	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	15.17	11.85	0.95	6.64	0.47	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	12.64	13.34	1.40	0.70	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	9.89	0.00	6.59	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	23.27	11.42	1.01	1.16	0.58	0.14	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	51.18	19.32	1.02	3.73	1.36	0.68	0.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	50.30	12.41	0.64	3.39	0.97	0.32	0.81	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	10.76	8.97	0.45	0.45	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	9.08	5.59	1.05	0.35	0.35	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	12.32	5.72	0.00	2.20	0.44	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	32.89	13.91	0.42	0.84	1.69	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	51.94	13.92	0.83	3.32	2.08	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	66.83	14.70	0.67	3.34	0.67	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	24.20	14.96	0.82	3.54	0.00	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	24.12	20.37	1.61	3.22	0.54	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	17.93	0.00	5.38	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	32.64	19.66	0.74	3.34	1.48	0.19	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	40.07	16.03	0.65	4.33	0.87	0.43	0.65	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	51.49	15.97	0.63	4.41	1.47	0.21	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	7.08	4.55	0.00	2.53	0.51	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	9.10	9.10	0.87	1.30	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	17.00	5.23	0.87	0.87	0.44	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	19.79	10.89	1.98	3.96	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	10.16	9.23	0.00	3.69	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	6.98	9.77	0.00	4.19	1.40	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	9.69	5.26	0.55	0.83	0.28	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	14.97	4.17	1.23	2.21	0.49	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	20.02	10.78	0.00	3.08	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	14.68	12.89	1.07	4.30	0.72	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	8.31	11.08	0.00	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	12.11	7.86	0.33	2.29	0.33	0.65	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	7.13	12.01	0.38	1.13	0.00	0.75	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	17.42	13.38	0.76	3.79	0.76	0.25	0.76	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8.72	11.70	1.38	1.84	2.52	1.61	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.99	8.63	1.20	1.44	3.35	0.72	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	7.39	6.57	0.27	1.09	2.46	1.37	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	7.21	9.91	0.30	0.30	2.70	1.20	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.16	8.64	1.92	1.20	1.92	0.72	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.87	10.91	1.59	1.59	4.32	0.91	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	15.86	20.21	1.96	1.09	2.82	1.52	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	13.42	18.69	0.53	3.16	2.37	1.58	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	13.84	17.12	2.35	2.35	3.99	2.81	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	17.51	17.51	1.51	3.02	3.32	0.60	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.98	17.14	2.32	2.32	4.36	2.32	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.18	16.79	3.46	3.73	2.66	1.87	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	18.82	13.57	2.63	2.63	7.88	0.88	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	23.68	11.39	1.82	1.82	5.92	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	23.87	11.19	0.75	1.49	4.48	1.49	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.40	11.89	0.36	0.72	1.44	3.24	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.06	9.21	2.01	1.44	4.03	1.15	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.54	8.01	1.41	0.47	3.77	0.94	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	12.36	15.53	2.54	2.54	2.85	2.22	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	16.61	15.38	2.77	1.85	4.31	2.77	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.46	14.11	0.96	1.92	3.85	0.64	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	15.30	18.36	1.91	0.76	1.53	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.01	14.98	1.58	1.58	5.52	2.76	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	14.37	2.27	0.00	3.03	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.85	8.83	0.00	0.00	10.44	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	17.49	9.09	0.00	1.40	8.39	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	11.02	17.03	2.00	2.00	5.01	0.00	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	14.62	18.28	3.66	25.59	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	5.43	8.89	0.00	2.96	0.99	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	8.94	7.58	2.32	1.16	0.84	0.53	0.42	0.00
Chondrocyte - de diff, donor1	11261-116G1	21.49	4.51	2.43	1.73	1.39	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	8.17	4.26	1.78	2.13	1.42	1.07	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	3.53	7.05	1.02	1.25	1.25	1.02	0.57	0.00
Chondrocyte - re diff, donor2	11339-117F7	8.95	0.00	0.00	0.00	1.79	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.09	4.85	0.00	1.62	0.00	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	8.26	8.03	2.07	0.92	1.38	0.11	0.80	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	7.05	8.12	1.71	0.64	0.43	0.43	0.86	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	6.11	4.69	1.59	1.42	0.71	0.35	0.88	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	8.71	6.97	2.75	2.11	2.38	0.37	0.46	0.09
Corneal Epithelial Cells, donor1	11526-119I5	10.54	7.47	0.88	1.10	1.98	0.44	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	6.83	1.14	0.00	3.41	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.97	6.65	0.26	1.79	1.79	0.77	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.03	6.60	0.50	1.32	1.82	0.66	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.15	9.15	0.00	0.95	1.58	0.95	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	9.94	6.48	0.54	1.73	1.51	0.43	0.22	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	8.20	4.78	0.00	1.02	0.68	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.65	1.96	0.00	0.00	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	5.32	2.42	0.00	0.97	0.00	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	5.84	4.84	1.67	1.00	0.67	1.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	6.45	8.80	1.17	0.00	0.59	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	4.52	7.07	3.11	0.00	0.57	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	5.90	4.33	0.79	1.18	1.18	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.53	5.24	1.45	2.04	0.29	0.58	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	12.47	10.12	1.88	1.65	0.94	0.71	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	8.94	5.61	2.63	1.40	0.88	1.40	1.05	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	4.88	5.10	0.22	1.11	0.22	0.22	0.66	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	3.96	3.35	1.52	0.30	1.22	0.61	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	3.10	2.26	0.28	0.00	0.85	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	6.83	2.08	0.89	0.30	0.89	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	5.21	3.64	1.56	1.04	1.56	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	2.41	2.84	0.57	1.13	0.28	0.14	0.57	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	14.40	0.80	1.20	1.60	1.20	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	8.91	6.29	1.57	0.00	0.00	2.62	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	8.57	6.21	1.74	1.12	1.62	0.37	0.87	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	3.26	2.17	0.22	0.87	0.22	1.52	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	4.40	3.30	1.34	1.59	0.73	0.61	0.61	0.00
Endothelial Cells - Vein, donor1	11267-116G7	5.69	3.41	2.28	1.14	4.55	2.28	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.08	6.99	5.59	2.10	2.10	1.40	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	4.55	4.87	1.73	2.36	0.79	1.57	0.31	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	3.30	0.00	1.65	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.24	10.75	2.20	1.71	1.95	0.98	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	27.04	0.00	2.08	2.08	2.08	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.73	3.69	0.41	1.64	0.00	0.41	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.07	1.09	0.55	0.66	0.33	0.22	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.67	6.83	1.30	1.52	0.43	1.08	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	6.67	6.91	1.70	0.49	1.09	0.12	0.24	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	5.19	3.55	0.14	0.41	0.68	0.27	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	4.54	5.17	0.95	1.37	0.21	0.42	0.42	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	3.16	1.84	0.53	0.26	0.26	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	9.97	7.97	0.66	1.99	0.33	1.33	1.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	4.08	4.54	0.91	2.72	0.45	0.91	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.82	5.31	3.03	0.76	0.00	2.27	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	4.73	7.25	1.10	1.42	0.79	1.10	1.10	0.00
Fibroblast - Cardiac, donor4	11452-119A3	6.37	6.37	0.91	2.73	0.61	0.61	1.21	0.00
Fibroblast - Cardiac, donor5	11456-119A7	9.14	3.55	1.52	2.28	0.63	0.51	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	8.94	4.24	1.21	1.97	1.21	0.00	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	6.97	2.41	2.14	1.21	0.94	0.54	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	7.77	7.33	0.86	2.16	0.00	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	10.25	1.46	2.93	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	3.46	3.00	1.61	0.92	0.23	0.69	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	6.61	8.65	2.54	1.70	0.34	1.19	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	6.10	7.51	1.88	0.70	1.17	0.47	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	8.96	4.25	2.36	0.47	0.47	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	6.04	8.58	1.09	1.93	0.36	0.36	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	16.62	3.84	2.37	2.26	0.68	0.11	0.68	0.00
Fibroblast - Dermal, donor5	11454-119A5	21.28	4.88	1.92	2.27	0.87	0.52	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	25.34	5.52	3.09	2.44	1.30	0.65	1.79	0.00
Fibroblast - Gingival, donor1	11237-116D4	6.46	4.58	1.04	0.21	0.62	0.21	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	8.12	6.03	1.83	1.57	0.79	1.05	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	9.88	9.62	1.58	1.19	0.40	1.05	0.53	0.00
Fibroblast - Gingival, donor3	11394-118C8	5.80	3.87	2.03	1.06	0.68	0.87	0.77	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	5.19	5.19	1.04	0.00	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	5.81	4.05	1.06	0.88	0.70	0.70	0.53	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	8.73	4.37	2.49	0.78	0.62	0.47	0.62	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.14	7.17	1.49	0.54	1.08	0.41	0.54	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.41	16.59	7.06	4.23	1.06	3.18	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	9.51	3.80	1.46	0.88	0.15	0.29	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	6.41	3.00	0.82	0.27	0.68	1.09	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	13.71	4.61	1.97	2.41	1.32	0.55	0.66	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	6.16	3.96	2.35	0.44	0.15	1.03	1.76	0.15
Fibroblast - Lung, donor1	11270-116H1	21.75	9.52	2.72	4.08	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	4.48	7.46	2.98	1.49	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	10.76	12.03	2.74	2.53	0.21	0.84	0.84	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.83	1.67	3.33	2.50	2.50	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	1.40	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.96	3.64	1.12	0.28	0.28	0.28	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	5.28	8.53	1.62	0.41	0.41	1.22	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	15.98	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	11.25	11.06	2.91	1.55	0.39	0.19	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	7.89	10.62	3.49	1.06	1.21	0.46	0.91	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	6.43	2.45	0.61	1.22	0.31	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	4.20	2.29	2.29	0.00	0.76	1.14	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.29	3.78	0.27	0.54	0.81	1.08	1.08	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	4.99	4.06	1.51	1.28	0.12	0.70	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.84	8.95	2.21	1.22	0.77	1.22	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.30	4.88	2.03	1.02	0.81	1.02	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.71	8.02	2.00	0.67	0.00	2.67	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	6.72	5.93	0.40	0.79	1.58	0.79	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9.53	1.19	1.19	0.60	0.60	0.60	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	5.68	6.57	0.53	0.89	0.18	0.53	0.71	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	9.07	5.52	1.18	1.18	0.39	0.79	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	13.54	4.21	0.60	1.20	0.30	0.60	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	9.93	2.70	1.08	1.30	0.65	0.65	0.43	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	6.83	1.77	0.00	0.51	0.25	0.76	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	4.76	3.94	0.16	0.33	0.66	0.49	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	17.44	7.82	0.00	0.80	1.00	0.20	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	15.87	3.72	1.81	1.61	2.01	0.40	0.60	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	18.13	4.23	1.21	0.60	0.60	0.00	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	11.52	6.38	1.33	1.41	0.41	0.75	0.08	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	9.74	3.08	1.54	0.85	1.03	0.00	0.68	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	2.96	1.64	0.66	0.99	0.66	0.00	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	12.14	4.15	1.49	1.17	1.92	0.11	0.75	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	8.94	7.25	2.19	0.67	0.51	0.84	0.51	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	3.45	5.65	1.10	0.94	0.78	0.63	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	288.08	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	12.20	2.61	0.00	3.49	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	5.03	2.95	0.35	0.17	1.04	0.52	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.07	4.68	0.52	0.52	1.30	0.26	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	9.45	5.62	0.51	0.51	1.28	0.51	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	43.64	26.03	10.72	7.66	9.95	3.83	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	36.37	20.42	8.29	6.38	4.47	3.19	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	26.81	22.54	2.00	7.13	7.42	0.86	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	47.71	28.68	15.99	10.75	3.31	1.10	4.41	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	45.89	22.83	9.36	4.79	2.51	1.37	2.97	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	51.12	27.94	5.55	10.50	5.94	0.79	2.18	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	56.83	22.20	9.78	10.57	2.38	0.53	5.29	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.29	13.70	8.48	5.22	2.28	0.65	2.61	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	24.76	21.67	2.21	6.63	3.54	0.88	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	14.70	16.68	5.51	3.67	2.12	1.27	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	8.74	9.85	4.19	0.99	2.22	1.23	1.23	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	10.75	13.97	4.03	1.61	1.61	1.61	1.61	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	9.66	8.80	3.22	1.98	1.24	0.87	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	9.97	7.20	2.77	1.25	2.35	1.11	1.80	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	5.90	9.76	1.22	1.22	1.42	0.81	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	10.50	15.52	2.28	1.37	0.91	1.14	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	9.84	8.60	3.86	1.74	1.49	1.12	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	8.74	8.74	2.40	1.09	0.66	1.09	1.75	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	10.64	20.39	1.18	1.77	0.89	2.36	2.07	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	10.33	12.88	3.97	2.23	1.43	0.32	0.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	10.28	13.85	2.01	2.01	1.79	0.89	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	10.08	20.36	4.23	2.42	1.01	0.40	1.21	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	12.89	11.03	3.05	2.54	1.19	1.02	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	10.37	12.59	2.84	1.42	0.89	0.53	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	9.89	10.93	3.12	1.35	0.42	0.73	0.94	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	11.78	5.64	3.07	1.71	0.51	0.68	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	13.28	11.18	1.88	1.99	1.11	0.22	1.44	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.89	11.65	2.16	1.16	1.00	0.83	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	12.05	7.35	2.65	1.43	2.25	0.61	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	10.11	16.92	2.27	1.44	1.03	0.62	1.44	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	14.07	12.45	3.80	1.96	0.81	0.81	1.04	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	8.67	11.34	0.67	1.33	1.50	0.67	1.67	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	7.49	14.99	4.19	1.10	0.44	0.44	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	12.91	10.82	3.20	1.60	0.49	0.37	1.60	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.10	13.13	2.43	1.30	0.81	1.13	0.65	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.62	21.49	2.89	1.28	1.28	0.96	1.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	10.71	11.84	2.94	1.99	0.85	0.66	0.95	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	9.17	10.28	1.74	0.95	0.95	0.32	1.27	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	12.16	10.64	3.65	0.00	0.61	0.30	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	11.92	10.87	2.09	1.67	0.52	0.42	0.73	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	9.22	8.78	2.20	1.32	0.22	0.66	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	11.50	11.78	2.81	1.40	1.12	0.56	0.84	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.04	5.65	2.41	1.11	0.56	1.20	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	8.02	9.36	1.07	1.07	1.60	0.53	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	5.36	6.27	0.61	0.46	0.15	0.46	1.38	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	6.74	7.12	2.07	1.30	0.52	0.65	0.39	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	4.34	6.51	1.08	0.81	0.81	0.81	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	5.90	10.14	2.40	2.58	0.37	0.55	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	10.97	13.60	3.07	1.97	0.44	0.88	1.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	3.97	4.96	5.95	0.99	0.00	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	4.75	9.76	1.85	1.19	0.53	0.92	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	9.48	12.91	1.61	1.21	0.61	1.01	1.41	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	2.03	0.76	1.27	0.76	0.00	0.25	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	11.94	6.37	2.59	2.79	2.79	0.60	1.39	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	9.40	11.25	4.01	3.24	2.77	1.08	2.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	6.96	15.55	3.48	2.25	4.50	0.61	1.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	38.49	20.34	5.32	8.76	5.63	1.25	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	25.15	16.67	4.80	3.96	3.39	0.57	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	11.99	7.38	4.61	1.84	2.31	0.46	2.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	19.80	7.42	14.85	2.47	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	11.60	9.67	5.03	1.93	5.03	2.32	3.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	22.46	9.63	4.81	0.00	3.21	0.00	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	6.96	10.43	6.96	1.74	1.74	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	18.23	10.42	4.88	2.60	5.53	1.30	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	15.24	12.77	3.71	2.06	3.29	2.06	2.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	29.99	6.66	3.33	3.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	16.22	12.30	4.75	1.68	3.92	1.68	1.40	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	12.09	11.44	6.54	1.96	4.58	0.33	1.31	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	24.33	15.94	5.87	3.36	3.36	2.52	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	16.22	14.00	5.09	2.23	3.18	2.23	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	21.06	14.95	3.40	3.06	3.40	1.36	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	16.71	0.00	0.00	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	18.90	13.17	5.15	2.29	1.15	1.15	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	19.53	8.88	4.74	3.26	2.07	0.89	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	11.86	10.16	3.39	1.69	3.39	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	10.77	10.77	4.56	0.83	3.31	1.24	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	17.95	9.90	5.29	0.92	2.53	1.15	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	10.54	0.00	5.27	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.84	9.99	2.31	2.31	0.38	1.54	1.54	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	11.08	5.87	2.93	0.33	1.96	0.65	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	11.37	6.02	1.34	2.01	2.68	0.67	2.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	9.63	10.79	3.85	3.08	0.77	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	13.01	7.19	4.11	1.37	4.11	1.03	1.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	19.88	4.97	7.45	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	20.76	16.51	7.08	3.30	0.00	1.89	2.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.90	9.05	3.62	3.02	3.02	1.81	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	16.79	11.19	3.05	3.56	1.02	0.51	2.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.14	10.77	4.79	2.39	3.59	0.40	2.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.80	13.32	3.95	1.48	0.99	2.47	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	16.53	9.44	2.36	3.54	1.18	0.00	4.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	19.25	15.75	4.08	3.50	1.17	1.17	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	12.29	10.09	3.95	1.32	1.76	0.88	2.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	12.72	16.11	3.39	1.70	2.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.13	17.91	2.39	2.98	2.39	0.60	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.68	3.88	0.49	0.49	1.94	0.49	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	3.42	3.42	1.14	2.28	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.41	3.33	0.00	0.83	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	16.87	7.87	0.00	3.37	1.12	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	4.12	5.39	0.32	0.63	0.63	0.00	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.18	4.60	0.00	0.42	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	18.57	13.46	2.09	1.39	1.39	0.58	0.58	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	14.18	11.65	1.86	2.36	2.03	0.34	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	11.60	11.15	1.14	0.91	0.91	1.59	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.32	13.44	1.42	1.09	0.66	0.55	0.55	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	13.11	12.04	1.72	1.07	1.50	1.50	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.98	11.41	2.15	1.72	1.51	0.86	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	13.82	11.71	0.50	1.25	0.75	0.75	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.52	8.92	1.37	0.34	0.34	0.86	0.51	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	11.85	8.97	1.28	1.60	1.28	0.32	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	2.80	2.24	1.68	1.12	0.56	1.12	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	13.42	6.92	0.87	1.30	0.43	1.73	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	0.00	5.29	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.93	6.00	2.12	1.76	0.71	1.06	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.08	7.99	2.18	0.73	0.73	2.18	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	13.99	7.52	0.87	0.87	0.35	0.00	0.35	0.00
Hepatocyte, donor1	11523-119I2	1.21	1.21	0.00	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	6.46	9.70	1.08	3.23	1.08	3.23	0.00	0.00
Hepatocyte, donor3	11684-122I1	0.61	1.23	0.00	0.61	0.61	0.00	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	69.18	39.16	3.26	9.79	6.53	0.65	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	6.29	6.12	1.40	0.70	1.40	0.52	0.52	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.08	4.12	2.06	0.41	0.27	0.55	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	63.68	28.66	3.18	6.37	0.00	3.18	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	47.07	27.69	4.15	1.38	0.00	2.77	6.92	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	22.52	0.00	5.01	0.00	0.00	10.01	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	106.81	0.00	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	53.82	17.94	0.00	2.56	0.00	12.81	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	13.71	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	50.35	19.49	3.25	3.25	3.25	3.25	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	41.68	20.01	6.67	1.67	0.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	3.63	3.63	0.00	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	46.32	30.44	3.97	1.32	3.97	0.00	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	36.59	25.50	2.22	2.22	0.00	2.22	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	10.48	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	41.57	20.16	3.15	1.89	0.00	5.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	26.29	1.55	7.73	3.09	3.09	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	58.14	34.89	3.23	1.94	2.58	4.52	1.29	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	49.91	37.03	4.83	3.22	0.00	6.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	95.59	11.95	11.95	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.93	26.89	8.15	4.89	0.00	2.44	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	24.35	31.07	1.26	1.68	1.68	2.10	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	31.34	31.34	3.21	1.61	2.41	4.02	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	34.16	21.24	8.31	1.85	1.85	4.62	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	30.16	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	25.96	19.35	0.94	0.94	1.42	2.36	1.42	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	38.09	26.30	6.35	1.81	0.00	0.91	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	30.13	25.83	5.38	2.15	1.08	1.08	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	29.22	27.95	5.08	1.27	2.54	7.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	33.80	22.32	3.19	2.55	0.64	3.19	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	38.28	34.63	5.47	3.65	3.65	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	110.63	15.80	0.00	15.80	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	52.13	30.70	3.57	1.43	3.57	0.71	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	23.23	3.32	3.32	6.64	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	25.00	18.83	3.09	1.54	1.85	2.47	1.85	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	24.58	5.27	1.76	1.76	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	44.00	28.29	3.14	3.14	3.14	12.57	6.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	54.24	30.60	5.56	4.17	2.09	4.17	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	30.98	8.85	0.00	2.21	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	16.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	23.54	15.69	4.36	0.87	1.74	3.49	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	11.25	6.75	6.75	4.50	4.50	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	10.45	6.97	10.45	3.48	3.48	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	35.20	28.80	3.20	7.47	0.00	2.13	3.20	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	42.95	37.41	6.93	4.16	1.39	5.54	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	11.40	8.55	2.85	5.70	5.70	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	43.26	31.29	4.60	2.76	0.92	4.60	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	12.10	0.00	3.03	3.03	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	18.63	0.00	0.00	0.00	12.42	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	26.43	20.09	3.17	5.29	1.06	5.29	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.67	6.28	0.49	0.82	0.73	0.41	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	2.93	0.59	1.17	0.00	0.00	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	7.86	3.12	0.66	0.95	0.76	0.38	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	14.42	12.60	1.82	1.25	0.34	0.57	0.45	0.00
Keratocytes, donor1	11527-119I6	2.75	2.06	0.69	0.69	0.34	1.03	0.69	0.34
Keratocytes, donor2	11607-120I5	4.69	2.34	2.34	3.52	0.00	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	5.34	6.92	2.37	0.79	0.20	1.19	1.58	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	8.79	0.00	0.00	0.00	6.59	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	4.31	6.47	2.16	1.08	1.08	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	6.80	8.19	1.96	1.38	1.85	0.92	1.27	0.00
Lens Epithelial Cells, donor3	11690-122I7	4.04	5.55	1.41	1.61	0.81	0.40	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	4.51	3.32	0.24	0.47	0.24	0.24	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	1.67	3.63	1.12	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	3.46	1.89	0.63	0.16	0.79	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	1.08	2.69	0.00	0.00	0.00	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.15	1.26	0.32	0.95	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.34	3.34	0.32	0.32	0.22	0.00	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	2.46	2.87	0.00	0.00	0.41	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.29	2.28	1.26	0.51	0.00	1.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	1.83	2.67	0.84	0.28	0.28	0.70	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	1.19	0.40	0.40	0.00	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	3.88	2.52	1.16	0.39	0.58	0.19	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.59	4.63	0.74	0.19	0.74	0.37	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	0.35	1.74	1.39	0.35	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	4.53	1.91	0.48	0.72	0.72	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	2.61	3.02	0.27	0.55	0.41	0.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	2.46	1.85	0.92	0.31	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.43	2.81	0.31	1.25	0.00	0.31	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	4.21	2.38	0.55	0.00	0.55	0.55	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.29	2.63	0.99	0.66	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.22	2.64	0.29	0.29	0.00	0.29	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.99	2.74	1.24	0.25	1.00	1.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	1.45	2.42	0.48	0.00	0.00	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	1.35	3.23	0.81	0.54	1.62	0.54	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	3.18	2.72	0.00	0.15	0.45	0.30	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	2.07	0.00	0.52	0.52	1.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	2.30	2.93	0.63	0.63	0.63	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.01	1.95	0.60	0.15	0.00	0.30	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	3.44	2.75	1.38	0.00	0.00	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	2.26	3.39	0.19	0.38	0.19	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2.97	2.12	1.17	0.21	0.32	0.85	0.42	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.39	5.33	0.97	0.00	0.97	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.65	4.96	0.99	0.66	1.32	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	3.47	2.85	0.62	0.50	0.87	0.62	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	1.85	0.74	0.74	0.37	0.37	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.71	3.71	0.25	0.49	1.24	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.02	3.02	0.41	0.27	0.41	0.69	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	2.89	1.61	1.93	0.32	0.32	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	2.13	2.13	0.61	0.30	0.61	0.91	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	3.22	3.22	0.70	0.28	0.14	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	1.42	2.49	0.71	0.00	0.71	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	2.42	0.48	0.48	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.05	3.42	0.93	0.31	0.78	0.47	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.73	3.94	1.43	0.36	0.36	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.57	2.29	0.33	0.65	0.65	0.98	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.65	1.41	0.47	0.47	0.24	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.55	5.45	1.49	1.11	0.12	0.62	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.59	2.05	1.02	0.51	0.77	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.69	2.09	1.49	0.30	0.30	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	13.60	4.53	2.27	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	33.75	33.75	8.44	5.37	2.30	2.30	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.95	14.10	5.20	1.48	3.71	1.48	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	49.51	29.62	5.50	2.96	2.54	1.27	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	35.87	23.21	2.11	0.70	2.81	2.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	24.28	13.08	6.54	0.93	1.87	0.93	0.93	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	37.61	17.52	5.67	2.06	0.52	1.55	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	33.30	27.36	0.00	0.00	0.00	4.76	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	20.36	28.05	3.62	3.17	2.49	3.62	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	43.33	18.03	3.20	2.91	1.74	2.33	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	28.36	25.66	3.15	0.90	3.60	1.35	2.25	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	29.26	27.64	4.34	2.71	1.90	2.17	1.63	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	65.22	23.62	3.08	3.59	2.57	2.57	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	39.17	20.82	4.23	3.18	2.12	3.88	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	24.65	17.99	4.00	2.67	1.33	1.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	72.84	19.36	5.60	1.53	1.02	1.53	2.04	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	26.41	19.48	2.93	2.67	2.93	2.67	1.60	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	34.77	17.95	4.91	2.65	3.78	0.76	1.51	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	58.90	20.86	4.29	3.68	2.45	3.68	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	49.74	27.72	5.71	3.26	6.52	1.63	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	29.15	22.49	2.92	2.50	3.12	3.33	0.83	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	46.80	20.18	3.64	3.36	2.24	1.40	0.28	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	31.94	24.73	3.09	5.15	2.06	1.03	4.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	33.38	27.29	5.52	4.35	3.19	1.74	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.99	16.74	5.08	1.79	0.60	1.49	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	20.47	22.68	3.32	2.77	1.11	5.53	2.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	37.12	34.64	7.07	4.95	2.47	2.83	3.89	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	42.41	20.65	2.58	4.43	3.32	3.32	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	28.78	3.45	1.15	3.45	3.45	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	29.17	19.96	4.61	3.84	3.84	5.76	1.92	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	44.16	27.17	2.26	0.00	3.40	1.70	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	30.36	23.79	2.46	2.46	3.28	2.46	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	30.28	20.79	6.33	3.16	2.71	1.81	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	38.78	15.08	2.87	3.59	1.44	2.15	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	37.35	29.88	2.99	2.24	1.49	1.49	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	33.07	31.96	5.57	3.34	3.34	2.60	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	41.35	16.37	6.46	2.15	0.00	1.72	1.72	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	39.39	28.26	2.57	1.71	0.86	3.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	37.65	35.32	4.66	1.33	2.00	2.67	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	55.50	25.94	2.41	2.41	1.81	2.41	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	36.97	29.86	5.69	4.27	0.71	2.84	2.84	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	48.46	34.03	3.44	3.78	3.44	2.06	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	61.19	23.08	4.83	2.68	3.22	1.07	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	53.87	38.38	6.06	2.69	4.71	4.04	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	55.56	31.86	6.30	2.96	2.96	2.59	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	20.93	4.65	1.16	6.98	2.33	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	45.48	28.56	6.35	5.29	6.35	1.06	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	42.82	29.61	3.60	3.20	2.40	3.20	1.20	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	53.06	15.99	6.54	2.91	1.45	0.73	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	42.92	34.49	6.13	5.37	2.30	2.30	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	34.04	24.17	5.92	2.96	4.44	2.47	1.97	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	45.16	18.82	3.76	3.76	0.94	2.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	47.77	28.66	5.53	5.53	4.02	2.01	2.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	38.30	21.18	3.15	1.80	2.25	1.35	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	32.70	18.93	1.72	1.72	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	39.19	36.07	5.34	2.67	1.78	1.78	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	31.67	28.15	6.26	3.91	4.30	1.96	1.17	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	56.08	20.45	4.62	1.32	1.98	2.64	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	41.00	30.10	5.19	5.19	3.11	3.11	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	33.26	23.19	4.81	2.63	3.94	4.81	1.75	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	49.76	17.89	5.59	2.24	3.35	1.12	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	38.86	23.41	5.30	2.65	1.32	0.44	1.32	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	40.89	24.69	5.79	3.47	1.93	1.54	1.93	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	42.53	18.23	3.04	4.56	2.53	2.53	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	37.01	18.26	2.88	2.88	1.92	2.40	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	34.98	27.03	5.57	2.39	2.78	1.59	2.39	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	50.43	16.41	3.04	2.43	2.43	2.43	1.82	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	32.51	11.07	2.08	2.77	3.46	1.38	2.08	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	34.58	23.56	4.56	2.66	3.04	2.28	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	50.61	20.66	5.16	4.13	2.58	2.58	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	28.42	10.28	2.42	0.00	1.21	1.81	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	27.57	29.79	6.02	2.85	2.85	2.54	3.17	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	35.18	21.32	3.20	3.20	2.67	2.13	1.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	41.38	8.05	2.30	1.15	2.87	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	36.00	33.43	8.23	4.11	4.63	1.54	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.25	15.56	4.95	2.12	2.83	4.95	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	38.02	7.38	3.97	1.70	6.24	3.97	1.13	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	33.70	28.29	5.41	1.66	4.16	5.82	0.83	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	34.45	13.31	3.92	1.57	0.78	3.13	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.47	6.26	3.34	1.67	3.76	1.67	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	20.44	21.84	6.97	1.86	0.46	3.25	1.86	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	42.82	11.37	3.35	2.01	2.01	4.68	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	33.15	11.76	5.88	0.53	1.60	3.21	2.14	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	33.54	17.78	5.66	2.83	4.04	2.83	1.62	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	44.97	24.78	7.34	4.59	2.75	2.75	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	60.46	5.33	2.67	0.89	3.56	2.67	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	55.28	25.64	3.99	6.27	2.85	6.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	75.92	23.77	4.60	2.30	1.53	6.90	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	71.13	14.77	4.38	0.55	2.74	0.55	2.74	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	49.44	35.19	7.57	2.67	2.67	4.45	1.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	50.17	40.03	7.28	5.46	3.12	3.38	1.04	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	86.87	13.93	3.32	4.64	6.63	5.30	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	145.50	37.41	6.24	4.16	10.39	4.16	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	10.48	6.38	0.68	0.46	1.37	0.46	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	8.44	7.16	0.18	1.47	2.39	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	9.04	5.11	0.92	0.92	1.44	0.79	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.12	0.00	0.00	0.53	0.00	1.59	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	4.44	1.11	0.48	0.63	0.32	0.95	0.48	0.00
Mallassez-derived cells, donor3	11930-125I4	5.00	2.64	1.25	0.42	0.97	1.11	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	2.69	2.29	0.70	0.00	0.30	0.30	0.10	0.10
Mammary Epithelial Cell, donor2	11350-117G9	4.34	2.03	0.00	0.29	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	5.49	4.99	1.00	1.25	1.75	0.75	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	10.06	10.92	0.87	1.73	1.51	0.22	0.54	0.00
Mast cell, donor2	11565-120D8	20.51	16.64	0.89	1.49	1.19	0.30	0.59	0.30
Mast cell, donor3	11566-120D9	14.63	8.78	0.45	0.68	0.68	0.45	0.45	0.00
Mast cell, donor4	11567-120E1	23.22	15.60	1.77	1.06	1.24	0.35	0.71	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	6.54	3.88	0.67	0.55	0.78	0.33	0.11	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	22.18	12.84	0.00	0.58	0.58	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	11.82	9.64	0.34	1.26	0.46	0.34	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	45.36	23.93	2.68	3.01	3.68	1.51	0.84	0.00
Melanocyte - dark, donor1	11502-119F8	5.57	5.77	0.40	1.69	1.19	0.60	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	5.88	7.27	1.04	0.69	1.04	1.04	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	17.39	14.42	1.88	2.39	0.87	0.43	0.43	0.00
Melanocyte - light, donor1	11274-116H5	8.93	5.88	0.94	1.41	0.94	0.47	0.24	0.00
Melanocyte - light, donor2	11351-117H1	9.55	6.82	4.78	1.36	1.36	0.00	1.36	0.00
Melanocyte - light, donor3	11423-118G1	4.34	6.94	1.73	3.47	1.73	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	23.01	15.93	2.39	2.08	0.83	0.83	1.15	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	13.45	8.07	0.00	1.34	0.27	0.27	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	6.16	5.09	1.61	1.34	0.27	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	12.53	4.22	2.73	1.24	0.87	0.12	0.87	0.00
Meningeal Cells, donor2	11573-120E7	7.04	0.88	2.64	0.88	1.76	0.44	0.88	0.00
Meningeal Cells, donor3	11654-122E7	12.55	9.86	2.45	0.73	0.82	0.16	0.57	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	10.27	9.98	0.57	1.71	1.43	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	4.13	3.32	0.50	0.30	0.60	0.20	0.30	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	21.03	3.94	2.63	6.57	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	9.16	2.62	2.62	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	14.35	9.33	1.44	0.72	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	3.81	1.69	0.85	0.21	0.21	0.00	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	7.54	2.51	0.50	0.50	1.01	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	15.16	9.23	1.76	1.32	2.42	0.66	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.80	10.23	2.92	1.46	1.46	0.00	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	14.94	11.25	3.07	2.66	1.84	1.02	0.61	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.83	2.35	1.66	1.11	0.69	0.28	0.83	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.66	10.04	2.60	2.23	0.74	1.12	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.00	13.42	1.84	1.18	0.39	0.66	0.79	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.64	5.93	2.08	2.08	1.19	0.30	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	4.67	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	9.61	2.56	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	9.92	11.70	1.42	0.71	1.42	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	9.07	10.95	1.88	0.94	1.56	1.25	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	8.71	7.98	1.45	0.73	0.73	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	2.92	3.18	0.53	1.59	0.27	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	1.50	2.00	1.50	0.50	1.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	2.53	2.46	1.23	0.51	0.51	0.51	0.22	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	5.40	1.35	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	9.60	4.19	0.25	0.99	0.99	0.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.07	3.83	0.59	0.88	0.59	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	6.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5.27	3.41	0.31	0.31	0.31	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	5.19	4.36	0.62	0.41	1.04	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	12.01	3.50	0.75	0.75	0.75	1.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	3.72	1.40	0.00	0.47	0.93	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.91	4.88	0.00	1.42	0.41	0.61	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	4.75	3.17	0.40	0.79	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	3.54	1.77	0.88	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.84	3.04	0.38	1.14	0.00	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00	0.00	1.32	1.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.91	3.61	0.00	1.06	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	0.92	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	5.96	2.68	0.00	1.49	0.60	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	1.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.53	2.01	0.75	1.76	0.00	0.50	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.04	1.66	0.24	0.71	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.11	1.11	0.00	0.00	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.07	2.30	0.46	0.00	0.69	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.00	2.52	0.00	1.05	0.42	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	2.45	1.02	0.61	0.82	0.41	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.86	2.79	0.00	1.29	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1.56	2.67	0.00	0.22	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.88	1.10	0.00	0.88	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.51	1.01	0.00	0.00	0.00	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.90	0.82	0.00	0.00	0.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.88	2.06	0.00	0.59	1.18	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	1.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.00	1.44	0.00	0.00	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1.20	1.20	0.00	0.00	1.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	0.00	0.00	1.00	1.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.31	0.44	0.00	0.00	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.00	0.00	0.00	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.50	0.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	0.70	0.00	0.70	1.39	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2.74	2.05	0.00	0.34	0.00	0.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.31	0.44	0.88	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2.13	1.42	0.00	1.07	0.36	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	1.12	0.28	0.00	0.28	0.56	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.83	1.25	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.00	0.00	0.00	0.58	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2.71	3.02	0.30	0.60	0.30	0.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1.67	0.00	0.00	0.83	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	3.41	1.71	0.00	1.14	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	2.90	1.24	0.00	0.41	0.14	0.55	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.66	1.04	0.26	0.00	0.00	0.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	3.00	0.86	0.00	0.43	1.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	1.27	0.00	0.64	0.64	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1.60	1.60	0.00	0.53	0.80	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	3.89	1.50	0.30	0.60	0.30	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1.98	1.55	0.14	0.28	0.28	0.71	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.10	1.91	0.00	0.32	0.00	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2.65	2.21	0.00	0.88	1.99	0.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.76	1.90	0.38	0.76	0.38	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	2.56	1.99	0.00	0.28	0.57	0.57	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.15	0.98	0.49	0.49	0.98	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.65	0.00	0.00	1.96	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	3.82	2.06	0.00	0.29	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.04	0.86	0.29	0.86	1.44	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.07	3.71	0.00	0.82	2.06	1.65	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	1.79	1.79	0.00	0.00	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	8.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	13.14	7.23	0.66	2.30	0.33	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	7.36	0.00	1.05	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.43	3.56	0.79	3.95	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	4.66	6.52	0.00	3.73	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	8.64	3.38	0.75	0.75	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	6.66	4.26	0.27	2.13	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	7.58	2.83	0.00	1.36	0.68	0.45	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	20.63	7.37	1.47	0.00	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.89	5.13	0.00	1.10	0.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	1.56	0.00	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.67	0.00	0.00	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	7.07	2.02	1.01	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	4.64	3.37	0.00	2.11	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	1.36	0.00	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	1.51	0.00	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	0.00	0.00	0.00	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	3.66	2.80	2.15	1.29	0.22	0.22	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	3.14	2.61	1.05	1.05	0.00	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.02	5.34	1.33	4.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	18.78	1.67	1.25	7.10	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.50	12.55	1.33	2.66	1.33	0.95	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	27.13	6.38	0.00	6.38	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.28	0.68	2.04	3.40	0.00	0.68	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	11.03	27.56	1.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.72	0.84	2.09	0.84	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.95	2.09	0.46	6.04	0.70	0.46	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.86	1.35	2.16	1.89	0.00	0.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	12.19	3.99	1.05	2.10	0.84	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	55.67	0.00	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.93	4.47	0.99	0.50	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.14	11.10	1.62	2.98	0.27	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	11.56	1.13	1.36	4.08	0.00	0.23	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.10	2.78	2.12	3.27	0.33	0.65	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.30	4.37	1.82	1.64	0.18	0.55	0.73	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.67	1.59	1.59	1.06	0.00	1.06	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.61	1.80	3.00	1.80	0.00	1.80	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.92	6.89	1.31	0.66	0.66	1.97	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.46	0.98	0.49	3.74	0.49	0.65	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	9.17	2.65	1.59	2.29	0.53	0.71	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.03	1.41	2.11	1.41	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.33	3.22	1.38	4.14	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.64	2.25	1.29	3.21	0.64	0.00	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	3.79	8.28	1.03	1.38	1.03	0.69	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2.53	30.34	15.17	5.06	5.06	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.13	3.12	1.78	2.45	0.45	1.11	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.55	2.54	0.85	4.66	0.00	1.69	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.82	3.80	0.95	2.37	0.24	1.66	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.02	3.43	2.15	3.00	0.00	1.29	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	99.31	9.03	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.00	3.00	1.33	3.33	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.47	1.35	0.45	2.25	0.45	0.00	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	12.70	1.98	0.00	4.36	0.00	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	24.14	0.93	4.64	4.64	0.00	2.79	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	8.32	6.05	2.27	4.92	0.76	1.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.78	1.96	0.98	2.93	0.65	0.98	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.10	0.00	3.49	4.79	0.44	0.87	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.66	1.81	0.00	1.81	0.00	2.26	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	1.76	0.88	0.00	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	23.27	3.32	3.32	3.32	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.88	0.50	0.99	2.98	0.99	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	15.31	1.53	3.83	2.68	1.15	0.77	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	20.87	8.47	1.51	6.05	3.02	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	7.29	2.43	1.55	1.33	0.88	0.44	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	13.55	2.03	2.71	3.39	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	45.99	0.00	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	16.46	3.66	2.44	1.22	1.83	0.00	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.70	0.94	1.57	2.83	0.31	0.00	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.41	3.93	2.72	6.05	0.00	0.91	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	23.73	6.33	1.58	3.96	0.00	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	4.53	13.60	2.27	3.40	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	40.46	10.12	0.00	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	5.47	4.35	0.87	0.25	1.61	0.00	0.00	0.12
Myoblast, donor2	11322-117D8	7.29	12.27	0.96	0.77	0.58	0.38	0.19	0.00
Myoblast, donor3	11398-118D3	10.76	6.39	0.17	1.35	1.85	0.67	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	23.93	9.34	1.61	5.40	2.63	0.15	0.44	0.15
Natural Killer Cells, donor1	11230-116C6	9.53	8.61	1.23	1.23	0.31	0.00	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	9.05	9.95	0.00	1.81	0.60	0.30	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	13.07	8.47	0.00	1.47	2.21	0.37	0.18	0.00
Neural stem cells, donor1	11275-116H6	7.98	4.36	2.90	1.45	0.73	1.81	1.45	0.00
Neural stem cells, donor2	11352-117H2	5.78	1.93	7.70	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	29.59	22.76	11.38	1.14	3.41	3.41	4.55	1.14
Neurons, donor2	11574-120E8	10.35	15.85	3.30	1.54	1.32	3.30	2.20	0.22
Neurons, donor3	11655-122E8	60.02	17.27	11.51	2.47	1.64	5.76	4.11	0.00
Neutrophils, donor1	11233-116C9	0.00	0.93	0.00	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	0.61	0.00	0.61	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	4.99	5.46	1.90	0.47	0.36	0.59	0.83	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	7.16	2.28	0.00	0.98	0.98	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	4.21	3.41	1.40	0.60	0.00	0.20	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	8.40	2.34	0.28	1.79	0.00	0.14	0.41	0.00
Olfactory epithelial cells, donor2	11934-125I8	12.16	4.20	1.16	1.74	0.14	0.72	0.00	0.00
Olfactory epithelial cells, donor3	11935-125I9	10.10	3.52	0.68	1.70	0.23	0.23	0.68	0.00
Olfactory epithelial cells, donor4	11936-126A1	9.54	6.72	1.27	2.14	0.00	0.78	0.49	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	14.44	16.25	1.81	2.41	0.60	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	18.72	6.17	1.91	5.10	0.64	0.64	0.85	0.21
Osteoblast - differentiated, donor2	11353-117H3	8.00	2.29	1.14	1.14	1.14	4.57	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.34	4.97	1.24	2.48	0.62	1.24	1.86	0.62
Osteoblast, donor1	11277-116H8	16.81	8.99	3.71	3.71	0.78	0.39	0.59	0.20
Osteoblast, donor2	11354-117H4	7.02	6.32	2.11	5.62	0.70	1.40	0.70	0.00
Osteoblast, donor3	11426-118G4	12.80	8.71	4.98	1.78	1.78	1.24	2.67	0.00
Pancreatic stromal cells, donor1	11249-116E7	8.09	6.06	1.18	0.67	0.84	0.76	0.08	0.00
Pericytes, donor1	11491-119E6	17.80	6.45	3.12	1.56	1.22	0.33	1.56	0.00
Pericytes, donor2	11571-120E5	10.87	4.30	2.72	2.04	1.13	0.91	1.13	0.00
Pericytes, donor3	11652-122E5	9.56	9.56	1.22	0.81	0.61	0.41	0.20	0.00
Perineurial Cells, donor1	11499-119F5	13.68	7.69	1.81	1.24	0.79	0.68	0.90	0.00
Perineurial Cells, donor2	11579-120F4	5.89	5.61	0.37	1.75	0.46	0.28	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	9.24	7.97	0.00	0.00	0.32	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	10.77	5.14	0.49	1.47	0.98	0.00	0.24	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	8.93	6.60	0.65	2.20	0.13	0.13	0.39	0.00
Placental Epithelial Cells, donor1	11278-116H9	14.35	7.17	2.63	0.48	0.72	0.24	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	4.44	4.44	2.22	1.11	2.22	0.00	4.44	0.00
Placental Epithelial Cells, donor3	11427-118G5	6.48	5.89	3.34	1.18	0.59	0.39	0.98	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.44	7.91	1.58	2.85	0.95	0.95	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	5.63	5.44	0.19	0.75	0.75	0.38	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.36	5.48	0.13	0.52	1.57	0.52	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	5.63	11.03	1.13	2.03	1.58	0.68	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	6.39	3.73	0.64	0.75	1.28	0.75	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	10.91	4.36	1.75	2.18	0.87	1.31	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	8.74	9.17	2.01	1.15	1.58	0.86	0.29	0.29
Preadipocyte - perirenal, donor1	11469-119C2	2.95	0.00	0.98	0.98	0.00	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	9.52	6.14	2.46	4.30	0.61	0.31	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	10.62	7.08	1.06	1.06	0.18	0.18	0.35	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	6.98	6.13	1.70	1.19	0.51	1.02	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	10.90	9.41	0.93	0.75	0.19	0.47	0.56	0.00
Preadipocyte - visceral, donor2	11357-117H7	4.60	1.84	0.00	0.92	0.00	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	14.21	3.66	1.36	1.36	0.73	0.00	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	7.54	8.45	3.92	0.00	2.41	0.75	1.36	0.15
Prostate Epithelial Cells, donor2	11331-117E8	4.87	4.87	2.17	0.95	1.08	0.95	0.41	0.00
Prostate Epithelial Cells, donor3	11404-118D9	6.43	4.16	0.80	0.67	1.96	1.16	0.61	0.00
Prostate Stromal Cells, donor1	11254-116F3	7.52	5.47	1.82	0.34	0.91	0.57	0.23	0.11
Prostate Stromal Cells, donor2	11332-117E9	5.20	5.20	1.97	0.54	1.08	0.72	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	3.96	5.11	1.46	0.73	0.63	0.83	0.83	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.12	8.39	3.65	2.55	0.36	1.46	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	8.18	6.79	1.39	0.83	0.62	0.49	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	17.25	15.22	5.58	2.03	0.00	1.52	1.52	0.00
Renal Epithelial Cells, donor2	11597-120H4	16.36	9.96	0.00	0.00	2.13	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	8.15	7.20	1.06	1.38	0.64	0.85	0.53	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	0.00	2.72	0.00	0.68	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.89	1.89	0.94	1.35	1.48	1.48	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	5.99	3.77	2.66	1.11	1.33	0.00	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	6.65	2.00	1.33	2.00	2.00	2.66	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.36	9.68	2.20	1.10	1.32	0.44	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	7.52	13.17	2.51	1.88	0.00	0.00	2.51	0.00
Renal Mesangial Cells, donor3	11679-122H5	5.55	7.49	4.16	1.66	0.00	0.55	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.05	5.64	0.54	0.54	1.07	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.90	4.64	1.27	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.52	8.29	1.35	0.58	1.16	0.19	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	5.19	9.07	0.52	2.07	1.30	0.52	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	6.82	1.42	1.99	2.84	0.85	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	9.26	1.03	2.06	1.03	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3.01	3.76	1.51	0.00	1.00	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	9.62	7.08	1.47	1.74	1.34	0.53	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	36.63	5.36	0.00	3.57	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	35.22	9.91	0.55	0.55	0.55	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.60	4.06	0.58	0.58	1.74	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	18.33	2.21	2.08	1.17	0.78	0.91	0.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	14.70	13.21	1.49	1.39	1.29	1.89	0.50	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	20.08	11.82	1.78	2.57	1.23	0.56	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	11.29	6.57	2.85	0.62	1.12	0.99	0.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.65	16.32	2.10	1.17	0.82	1.05	0.58	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	25.66	9.94	2.54	1.39	1.16	1.16	0.69	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	14.10	3.97	1.92	1.78	1.23	1.23	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	19.06	11.50	1.36	1.21	0.76	0.61	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	13.98	10.75	1.08	1.43	0.54	1.79	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.62	4.59	2.58	1.43	1.00	0.57	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.35	13.63	1.29	0.97	0.86	1.07	0.32	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	23.23	11.28	1.99	2.66	0.89	0.22	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.74	1.53	3.06	0.96	1.34	0.96	1.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	16.30	10.99	2.33	1.49	1.21	1.12	0.47	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.73	7.33	0.94	0.56	0.75	0.94	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	10.75	4.25	2.79	0.66	0.93	1.06	0.93	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	13.53	9.73	2.63	1.56	0.78	0.78	0.97	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	17.76	10.69	2.48	1.34	1.34	0.95	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.10	4.59	1.82	1.39	1.07	1.28	0.53	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	14.86	9.53	4.48	1.12	1.12	0.56	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	12.13	9.57	1.20	2.22	0.68	0.85	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	11.49	2.73	2.37	0.91	0.73	0.91	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	15.70	11.65	1.35	1.72	0.74	1.23	0.86	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	16.92	10.75	2.28	2.01	0.81	0.94	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	14.39	4.95	3.07	1.18	2.12	0.71	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	17.46	11.90	2.18	1.98	0.60	1.79	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	18.94	13.10	1.87	2.81	0.94	0.94	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	19.08	3.11	1.66	0.83	1.66	1.66	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	16.81	9.51	1.55	1.11	1.11	1.11	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	17.55	11.91	2.30	1.88	0.42	1.25	1.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	15.61	5.92	1.75	1.35	1.35	1.21	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	9.20	9.54	1.36	0.68	1.87	0.68	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.81	8.10	2.12	1.54	1.16	1.16	0.77	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	14.27	4.30	2.24	1.03	2.92	0.69	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	9.46	7.00	2.61	1.78	0.96	0.55	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	18.22	7.06	2.46	2.30	1.15	0.99	0.49	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	8.52	2.39	2.22	0.85	1.70	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	11.84	8.43	2.81	1.78	0.89	0.59	0.59	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	14.66	11.20	1.60	1.33	1.33	0.53	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	14.10	3.59	1.80	1.24	0.83	1.11	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	15.24	13.57	1.19	0.95	1.19	0.48	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	18.54	11.29	1.81	1.81	1.21	1.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	15.92	5.74	1.98	1.32	2.07	0.85	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	14.32	17.82	2.10	1.05	0.00	0.70	1.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	10.88	6.65	1.51	2.42	0.91	0.30	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.01	5.26	1.84	1.71	2.45	1.35	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	18.19	11.21	1.75	1.31	2.18	1.46	0.29	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	16.43	18.86	3.04	3.04	1.22	3.65	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	19.29	4.22	1.81	2.11	0.60	0.30	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	12.67	15.15	1.81	2.94	1.13	0.68	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	17.37	16.47	1.50	3.00	1.50	0.90	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.01	5.90	2.83	1.18	2.24	0.71	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	21.98	11.74	1.49	1.71	2.35	1.71	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	22.24	18.63	0.60	1.80	0.60	1.80	0.00	0.60
Schwann Cells, donor1	11498-119F4	15.61	4.14	1.88	2.26	1.50	0.19	0.38	0.00
Schwann Cells, donor2	11578-120F3	13.61	13.61	3.40	0.00	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	9.42	5.04	1.10	0.88	0.00	0.00	0.22	0.00
Sebocyte, donor1	11220-116B5	1.10	2.74	0.55	0.00	0.55	1.64	0.00	0.00
Sebocyte, donor2	11301-117B5	2.76	3.22	1.38	0.92	0.46	1.38	0.46	0.00
Sebocyte, donor3	11378-118B1	15.66	8.86	1.44	1.86	1.24	1.44	0.21	0.00
Sertoli Cells, donor1	11255-116F4	6.63	9.94	1.66	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	8.47	2.82	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	12.67	12.49	3.87	1.94	0.97	0.79	0.44	0.00
Skeletal Muscle Cells, donor2	11358-117H8	2.89	7.95	3.61	5.06	0.72	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	52.67	14.21	6.69	10.03	1.67	1.67	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	16.65	5.34	0.79	0.47	0.79	0.94	0.94	0.00
Skeletal Muscle Cells, donor5	11455-119A6	14.57	3.42	1.64	1.64	0.59	0.15	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	13.85	4.77	0.92	1.69	0.77	0.00	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	11.21	9.20	2.14	1.01	0.50	0.50	0.50	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	6.85	8.99	1.85	1.14	0.57	0.57	0.14	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	11.91	9.42	2.18	1.29	0.69	0.30	0.60	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	10.78	9.18	2.19	2.36	1.26	0.42	0.59	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	14.48	11.58	4.34	5.07	1.45	2.17	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	17.61	4.68	3.03	3.30	1.51	1.38	0.55	0.00
Skin - palm, donor1	10286-104F7	0.00	0.00	0.00	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.79	3.89	0.86	1.01	1.01	0.14	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	14.72	11.45	0.00	0.82	2.45	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.55	3.89	1.17	1.95	0.78	1.43	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	7.65	5.56	0.97	0.83	0.70	1.11	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	5.34	5.20	0.42	0.84	1.27	1.69	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	23.68	8.88	0.42	2.11	2.54	0.42	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	8.39	5.77	1.42	0.75	2.40	1.95	0.30	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.70	2.78	1.54	0.31	2.47	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	3.56	2.22	0.22	0.00	0.67	0.67	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	7.05	5.88	2.94	2.94	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.61	9.28	3.54	3.09	0.66	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	2.36	1.58	1.18	0.00	0.79	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.13	6.18	3.86	1.55	0.77	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	23.02	14.01	2.00	0.00	0.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	12.78	8.78	2.66	2.26	1.06	0.93	0.80	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	5.32	5.54	0.66	0.66	1.11	0.22	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1.54	1.15	0.90	0.90	0.51	0.00	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	5.86	3.26	0.33	0.33	0.65	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	5.32	3.25	1.48	0.59	0.59	0.00	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	1.42	1.42	0.28	0.57	0.00	0.57	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.67	7.81	3.74	1.14	0.98	0.33	0.65	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	5.48	5.48	0.30	1.83	0.61	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	17.43	17.43	2.53	3.79	0.51	0.51	1.26	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	61.21	30.60	0.00	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.64	3.34	2.38	1.91	0.48	0.48	1.91	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	4.13	3.39	0.59	0.59	0.44	0.15	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	2.15	3.01	0.65	1.72	1.08	0.00	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	5.14	3.15	1.47	0.73	0.63	0.42	0.42	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.60	5.72	0.93	1.39	0.77	1.08	0.62	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	1.08	0.00	1.08	0.00	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.16	1.79	0.90	1.49	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	13.66	9.22	2.05	0.68	1.71	0.00	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	10.05	9.03	1.49	0.71	0.24	0.31	0.55	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	7.35	9.56	2.52	0.70	0.70	0.91	1.01	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	2.05	2.50	0.91	0.00	0.00	0.46	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.87	1.81	1.21	0.60	1.21	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	19.07	5.56	1.32	3.18	1.06	0.79	0.79	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	11.58	2.66	1.20	0.67	0.67	0.53	0.67	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	5.01	4.13	2.25	0.75	0.50	0.38	0.88	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2.79	1.01	0.76	1.27	0.51	0.25	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.17	7.39	1.96	1.96	1.21	0.75	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	13.50	6.00	2.25	3.75	1.50	0.00	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	20.68	10.34	15.51	2.58	1.29	6.46	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.00	13.95	3.72	2.79	1.40	0.93	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	5.55	5.05	1.51	1.01	1.51	1.01	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.95	1.57	1.57	0.63	0.31	0.94	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.42	4.42	1.77	1.18	0.00	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	6.41	3.92	1.17	0.75	0.58	0.42	0.33	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.54	2.34	1.40	1.87	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13.10	4.17	1.73	2.73	0.43	1.15	0.58	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.22	6.88	2.80	2.04	1.02	1.27	1.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.73	5.26	2.63	2.26	1.13	0.75	1.32	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	7.69	5.17	2.10	0.42	0.84	0.00	0.56	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	3.85	5.61	0.84	0.67	0.34	0.50	0.25	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	11.43	8.57	0.00	3.81	0.48	0.95	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.87	4.40	1.96	0.98	1.22	0.49	1.22	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.72	1.55	1.55	1.10	0.66	0.00	0.44	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.66	6.73	2.34	2.05	0.29	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	5.44	4.47	0.78	0.39	0.19	0.58	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	6.35	2.91	0.79	0.79	0.00	1.06	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.67	1.86	0.37	0.00	0.37	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	4.67	3.59	1.80	1.44	0.00	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.10	2.84	0.57	0.57	0.85	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.00	4.33	1.97	1.18	0.39	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	6.86	3.81	1.52	0.76	0.25	0.51	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	5.99	7.99	0.40	0.40	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	12.12	4.18	0.42	1.67	0.00	1.25	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	9.17	4.13	1.38	0.92	0.00	1.38	0.00	0.00
Synoviocyte, donor1	11291-117A4	5.55	4.38	0.34	0.34	0.67	0.34	0.34	0.00
Synoviocyte, donor2	11368-117I9	7.21	8.55	0.84	2.01	0.50	1.17	1.01	0.17
Synoviocyte, donor3	11440-118H9	6.03	2.68	0.67	1.34	0.45	0.00	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	12.51	8.93	3.93	1.43	0.71	0.36	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	3.96	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.48	6.71	0.93	1.39	0.46	0.46	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	15.56	3.08	1.08	1.08	0.22	0.93	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	10.05	9.28	1.16	1.55	0.77	0.77	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.16	4.01	0.00	2.86	0.57	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	8.49	6.52	1.85	1.97	2.58	1.11	0.00	0.00
Urethra, donor2	10319-105A4	16.19	0.00	1.80	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	10.10	5.31	2.13	0.80	2.13	0.80	1.06	0.27
Urothelial Cells, donor2	11600-120H7	14.82	10.41	1.60	0.80	2.00	1.60	0.00	0.00
Urothelial Cells, donor3	11681-122H7	10.31	10.09	1.15	0.23	0.92	1.38	0.23	0.00
Urothelial cells, donor0	11216-116B1	12.93	8.25	0.89	1.56	0.89	0.89	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	8.01	2.67	0.89	2.67	1.78	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	8.58	2.86	0.00	1.43	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.85	6.16	0.00	0.00	1.37	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	12.05	6.54	0.69	1.03	0.69	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	13.94	11.04	0.00	0.58	1.16	0.00	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	7.29	2.08	0.00	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	15.60	2.75	0.92	0.92	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	5.48	5.48	0.00	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	23.19	18.63	10.61	2.22	1.36	2.34	2.22	0.37
Wilms' tumor cell line:HFWT	10597-108E3	9.68	6.16	2.64	2.64	0.88	0.88	2.64	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	25.42	10.61	0.56	2.79	2.79	0.28	0.28	0.00
achilles tendon, donor2	10292-104G4	6.20	2.07	0.00	4.13	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	41.30	17.59	3.06	3.57	1.27	0.51	0.76	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	31.58	15.56	3.48	3.95	1.39	0.46	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	28.85	24.10	4.39	3.44	1.66	0.24	1.66	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	62.86	25.85	5.71	9.25	4.35	0.54	1.09	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	36.26	29.23	4.50	3.37	0.84	0.84	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	15.65	15.65	1.48	1.90	3.60	1.27	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.14	13.34	0.54	2.99	3.54	0.54	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	24.68	11.02	1.76	5.29	3.53	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	43.69	21.64	2.04	3.27	1.23	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	44.65	13.59	4.66	7.77	3.11	0.00	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	14.54	13.06	1.47	0.92	1.47	0.55	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	11.70	0.00	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	25.79	14.87	5.11	2.56	2.32	0.93	2.56	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	31.07	19.94	1.81	1.81	5.18	0.78	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	15.78	15.78	2.34	0.88	0.29	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	11.15	6.51	0.46	2.79	0.93	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	32.49	14.81	0.41	3.70	1.23	1.65	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	22.71	7.67	0.00	2.46	4.91	1.53	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	32.43	11.52	1.28	2.13	5.97	0.43	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	13.65	7.58	1.21	1.52	1.52	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	20.46	13.96	1.44	0.48	2.17	0.00	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	14.70	14.92	0.22	1.56	1.11	0.45	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	22.68	12.01	1.33	2.33	3.34	1.00	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	3.72	3.72	0.00	1.86	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	17.70	7.16	1.13	1.88	0.00	0.75	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	26.60	11.78	1.74	6.11	1.74	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	11.25	1.87	0.00	3.75	3.75	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	25.67	8.71	0.71	3.30	0.71	2.35	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	10.24	5.43	0.47	1.86	1.55	0.16	0.16	0.00
adipose, donor1	10184-103D4	21.70	46.91	9.97	3.52	1.17	1.17	4.69	0.00
adipose, donor2	10185-103D5	44.20	18.25	11.76	8.11	0.00	1.22	4.06	0.41
adipose, donor3	10186-103D6	48.47	26.14	8.99	4.36	3.00	1.91	2.45	0.82
adipose, donor4	10187-103D7	86.68	58.94	5.20	7.80	3.47	0.00	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	32.20	13.10	11.05	6.47	6.63	3.00	2.84	0.47
adrenal gland, adult, pool1	10081-102A9	0.00	3.64	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	28.68	19.21	0.40	2.00	1.73	0.53	0.27	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	26.08	6.07	5.00	2.14	0.71	0.00	1.43	0.00
amniotic membrane cells, donor1	12235-129G3	16.93	6.96	0.70	1.62	2.55	0.46	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	15.55	8.79	4.40	1.01	2.37	0.68	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	8.54	5.89	0.00	1.18	4.71	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	3.56	2.37	2.37	0.00	0.00	7.11	0.00	0.00
amygdala, adult, donor10252	10151-102I7	6.29	7.10	4.87	5.68	1.01	2.84	2.64	0.20
amygdala, newborn, donor10223	10360-105E9	7.42	5.81	2.90	1.29	0.32	1.94	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	5.86	10.06	5.86	2.04	0.51	0.38	1.53	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	33.76	20.08	0.66	6.18	6.40	0.00	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	37.75	19.04	3.67	6.01	1.67	2.00	5.34	0.00
aorta, adult, pool1	10052-101G7	12.94	2.16	1.77	4.31	0.39	0.39	0.20	0.00
appendix, adult	10189-103D9	13.58	6.99	1.55	1.16	1.94	0.00	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.45	5.85	2.75	1.38	0.69	0.34	0.69	0.00
artery, adult	10190-103E1	5.43	4.08	0.00	1.36	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	8.69	9.56	2.75	0.72	0.43	0.58	1.16	0.00
b cell line:RPMI1788	10427-106D4	14.28	17.55	1.04	2.83	2.83	0.00	1.04	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.94	3.61	1.11	0.55	0.28	0.28	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	6.45	5.16	0.89	0.40	1.29	0.20	0.30	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	15.57	5.86	0.33	2.01	1.67	0.33	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	21.81	3.36	0.00	3.91	1.12	0.56	0.56	0.00
bladder, adult, pool1	10011-101C2	9.02	6.08	0.65	1.63	0.54	0.87	0.76	0.11
blood, adult, pool1	10053-101G8	13.29	2.21	0.00	6.64	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	13.70	1.71	0.00	0.86	1.71	0.86	0.86	0.00
bone marrow, adult	10192-103E3	8.10	4.72	0.67	1.35	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	22.55	2.05	6.15	1.03	1.03	2.05	4.10	1.03
brain, adult, pool1	10012-101C3	11.80	9.24	1.56	1.22	0.45	3.45	1.34	0.11
brain, fetal, pool1	10085-102B4	40.07	10.69	16.03	2.67	0.00	8.01	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	28.08	9.58	1.65	2.97	2.31	1.98	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	33.83	19.60	1.12	3.25	5.87	1.00	0.12	0.00
breast, adult, donor1	10080-102A8	37.88	6.94	0.00	11.36	0.00	1.26	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	22.99	8.64	2.16	1.78	2.03	0.25	0.76	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	15.46	4.33	1.86	0.62	0.00	0.00	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.45	4.14	0.69	0.46	0.46	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	30.74	8.96	0.00	2.66	1.45	0.48	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	45.14	16.93	2.82	3.29	5.17	1.41	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	7.11	5.36	1.31	0.55	1.20	0.88	0.44	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	41.83	13.94	1.58	3.80	1.27	1.58	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	42.59	18.63	6.12	3.73	1.60	1.86	2.13	0.00
caudate nucleus - adult, donor10196	10177-103C6	13.82	1.15	0.00	0.00	0.00	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	3.85	4.52	3.18	3.18	1.00	1.84	1.51	0.33
caudate nucleus, adult, donor10258	10379-105H1	8.41	4.58	1.53	0.00	0.00	3.06	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	12.45	5.86	3.30	1.46	0.37	1.83	1.46	0.73
cerebellum - adult, donor10196	10173-103C2	17.48	5.83	2.91	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	17.72	11.10	3.63	0.64	1.28	2.35	0.43	0.21
cerebellum, adult, pool1	10083-102B2	24.15	5.86	0.69	2.76	0.69	1.03	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	24.91	10.79	0.00	3.32	0.83	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	5.80	4.29	2.02	1.76	0.50	2.27	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	5.12	3.65	1.46	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	30.91	15.82	1.73	3.02	2.30	1.58	1.15	0.14
cervical cancer cell line:ME-180	10553-107I4	12.10	5.47	1.33	1.66	5.80	0.33	0.00	0.00
cervix, adult, pool1	10013-101C4	12.81	9.45	1.99	1.89	2.20	0.73	0.94	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	9.06	6.55	0.84	1.53	1.11	0.28	0.28	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	1.31	1.31	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	13.55	11.43	1.99	1.24	3.11	0.87	0.62	0.12
choriocarcinoma cell line:SCH	10785-110H2	16.14	13.55	1.97	0.86	4.81	0.12	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	8.06	7.35	1.66	1.19	4.03	0.00	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	10.26	5.13	0.28	1.71	1.14	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	12.13	9.45	2.59	1.59	1.09	0.80	1.59	0.10
chorionic membrane cells, donor3	12240-129G8	3.30	3.30	0.00	0.55	3.85	0.55	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	16.16	16.16	1.01	3.03	2.02	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	29.39	9.22	1.54	3.07	1.34	0.58	0.58	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	13.73	4.01	0.63	3.17	0.63	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	17.21	15.66	4.88	0.77	0.77	2.31	1.54	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	16.69	14.75	3.87	0.48	2.42	1.45	0.97	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.99	9.37	4.07	0.61	1.02	1.02	1.83	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	45.94	10.60	2.36	2.36	1.18	0.29	0.88	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	15.12	8.60	1.04	2.09	2.87	0.52	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.23	4.34	1.83	1.14	0.00	0.46	1.60	0.00
clear cell carcinoma cell line:TEN	10636-108I6	31.58	6.59	1.56	1.56	1.91	0.52	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	16.84	6.77	2.56	0.18	1.28	0.18	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	15.58	11.40	2.28	1.14	1.14	0.00	0.76	0.00
colon, adult, donor1	10082-102B1	39.27	10.71	1.19	5.95	2.38	0.00	3.57	0.00
colon, adult, pool1	10014-101C5	18.10	11.87	2.35	2.12	3.41	0.59	0.24	0.00
colon, fetal, donor1	10070-101I7	32.75	5.56	0.00	1.24	1.24	0.00	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	9.17	9.17	0.00	4.58	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	9.35	7.22	0.00	1.27	5.52	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	37.28	23.70	1.81	2.11	6.04	1.96	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	31.45	17.20	0.85	1.55	3.95	0.99	0.56	0.00
corpus callosum, adult, pool1	10042-101F6	14.26	18.24	2.87	3.65	1.77	1.11	1.33	1.44
cruciate ligament, donor2	10295-104G7	10.54	4.86	0.00	4.05	0.81	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	17.66	4.82	1.61	5.62	0.00	2.41	0.80	0.80
diencephalon, adult	10193-103E4	8.88	3.36	1.68	1.20	0.00	1.68	0.96	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	19.98	12.40	2.98	0.92	0.00	0.46	0.69	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	6.15	3.59	0.00	0.51	1.54	0.51	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	7.94	6.02	3.37	3.37	2.65	0.48	0.72	0.00
ductus deferens, adult	10196-103E7	8.97	7.48	1.50	1.00	0.50	1.00	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	4.32	5.76	5.76	0.00	2.88	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	13.24	10.30	2.21	2.21	2.21	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	3.55	3.80	1.07	1.24	1.24	0.41	0.33	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	3.78	0.89	0.89	0.00	0.67	0.22	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	17.91	6.30	2.01	0.43	0.72	0.00	0.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	10.48	1.23	1.23	3.08	0.00	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	10.59	2.72	1.82	3.33	0.30	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.34	1.85	0.93	1.23	0.62	0.93	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	2.63	3.94	0.00	0.00	1.31	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	7.04	0.67	2.01	0.34	1.01	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	19.21	9.06	1.99	4.35	0.91	2.17	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.11	3.38	0.48	2.09	1.77	0.32	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	9.78	6.22	0.33	1.11	3.22	0.44	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	6.93	10.45	3.63	1.43	1.21	0.44	1.32	0.00
epididymis, adult	10197-103E8	5.86	4.81	0.63	1.47	0.84	0.63	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	15.61	4.26	2.13	2.66	0.35	0.00	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1.18	0.39	3.15	1.18	1.57	2.36	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	26.60	23.46	3.41	3.28	6.16	1.57	1.44	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	17.13	19.68	2.85	2.56	4.43	1.67	1.08	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	19.94	22.97	3.36	2.58	3.47	1.23	1.01	0.11
esophagus, adult, pool1	10015-101C6	10.83	9.77	1.06	1.81	2.23	0.96	0.42	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	18.28	19.66	4.88	2.63	2.38	0.63	0.88	0.25
eye - muscle inferior rectus, donor1	10272-104E2	4.83	0.00	0.00	7.24	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	0.00	5.95	5.95	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	6.88	1.15	0.00	6.88	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	10.20	0.00	0.00	5.83	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	18.56	7.12	1.27	2.03	0.00	0.25	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	28.21	8.85	2.05	2.31	0.26	0.64	0.77	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	35.14	13.06	6.89	2.61	2.14	1.19	1.42	0.00
frontal lobe, adult, pool1	10040-101F4	8.54	7.04	2.91	1.22	0.28	4.13	0.66	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	33.93	12.91	2.10	2.40	8.11	0.60	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	15.18	6.40	2.93	1.10	0.18	0.73	1.01	0.00
gall bladder, adult	10198-103E9	10.86	5.31	1.21	1.69	0.72	0.97	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	28.99	10.74	0.54	5.37	0.00	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	17.93	10.46	0.37	1.49	0.75	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	14.15	7.60	1.48	1.69	2.96	0.63	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	9.86	6.38	3.29	2.51	4.06	0.97	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	26.89	18.04	9.67	3.61	3.12	2.62	1.80	0.33
gastric cancer cell line:GSS	10560-108A2	16.47	9.15	8.24	0.92	0.00	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.13	15.31	2.51	0.91	1.37	2.28	0.23	0.23
giant cell carcinoma cell line:LU65	10487-107B1	6.31	4.82	0.46	0.57	1.15	0.23	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	6.16	6.16	1.68	0.70	0.00	0.14	0.70	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	20.20	12.97	2.99	0.75	2.24	0.50	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.45	3.80	1.69	0.74	0.21	0.32	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	15.87	4.07	1.54	1.97	0.14	0.84	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	18.76	7.84	1.99	0.66	0.33	0.22	0.44	0.00
glioma cell line:GI-1	10413-106B8	13.47	7.91	2.34	1.46	0.88	0.88	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	10.93	2.19	3.64	4.37	0.00	0.73	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	15.87	15.87	1.22	5.86	2.20	1.46	2.20	1.95
globus pallidus, adult, donor10258	10367-105F7	23.28	2.74	1.37	8.22	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	20.78	10.66	2.66	3.20	0.00	6.40	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	2.45	9.79	0.00	7.34	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	21.86	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	15.68	0.00	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	9.92	1.92	0.32	2.24	0.64	0.64	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	13.31	11.94	5.51	4.59	0.92	0.00	1.84	0.00
hIPS +CCl2, biol_rep2	14384-156C1	7.32	10.06	2.29	0.91	1.83	0.91	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	10.31	8.37	1.29	3.86	2.58	0.64	0.64	0.00
hIPS, biol_rep1	14380-156B6	5.75	7.19	7.19	0.00	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	6.17	11.66	3.43	0.00	0.69	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	7.72	5.52	1.10	5.52	2.21	1.10	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	35.92	15.80	0.57	3.74	4.02	0.86	0.00	0.00
heart - mitral valve, adult	10205-103F7	4.48	1.49	0.60	0.90	0.90	0.60	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	6.28	3.66	2.09	1.31	1.31	0.52	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	4.16	5.00	0.83	5.00	2.50	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	14.28	4.08	1.43	3.26	1.22	0.00	1.63	0.00
heart, adult, diseased, donor1	10051-101G6	13.20	2.13	0.43	4.68	1.28	0.85	1.70	0.00
heart, adult, pool1	10016-101C7	10.35	8.51	2.30	2.07	1.61	0.46	0.46	0.23
heart, fetal, pool1	10046-101G1	10.99	10.78	3.39	2.57	1.33	1.33	1.03	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	7.40	4.01	0.62	0.93	0.31	0.00	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	24.97	5.95	3.57	1.19	2.38	0.00	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	15.14	10.61	7.29	2.32	0.88	0.99	1.99	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	16.14	12.87	8.01	1.82	1.21	1.09	2.43	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	13.74	11.22	6.87	1.82	2.22	1.11	2.12	0.40
hepatoma cell line:Li-7	10484-107A7	33.70	8.79	2.11	1.67	0.00	0.56	0.78	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	36.18	20.30	3.32	4.02	2.61	0.50	0.90	0.10
hippocampus - adult, donor10196	10169-103B7	12.30	0.00	0.00	2.84	1.89	0.00	0.95	0.95
hippocampus, adult, donor10252	10153-102I9	9.39	12.25	2.86	5.71	1.02	3.67	1.43	1.63
hippocampus, adult, donor10258	10374-105G5	5.48	5.48	1.49	1.00	1.00	5.48	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	11.98	4.23	3.52	4.58	0.70	3.17	1.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	21.36	15.87	1.22	1.83	5.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	20.22	14.14	2.16	3.34	3.34	0.00	0.98	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	19.30	21.07	2.29	4.57	3.05	0.25	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	30.45	21.99	9.59	7.89	1.69	1.13	4.51	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	37.96	20.66	7.75	4.13	1.81	1.03	2.07	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	29.99	17.46	7.97	1.52	1.14	0.76	1.14	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	24.52	10.80	8.76	2.34	1.75	1.17	0.88	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	26.71	10.13	6.89	4.52	0.65	0.43	4.31	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	22.10	11.68	5.00	3.34	2.09	0.83	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.65	13.97	5.68	2.37	3.55	0.47	2.60	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	39.54	18.16	7.07	4.66	1.45	1.77	1.29	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.20	9.43	4.04	1.35	2.69	0.67	3.37	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	20.03	16.59	2.19	4.38	4.38	0.78	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	20.14	15.23	1.47	5.90	5.40	0.98	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	25.31	14.84	1.75	0.87	4.36	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	55.36	21.38	11.65	6.68	1.72	2.10	3.82	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	48.40	24.42	11.34	6.98	3.05	0.87	2.62	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	49.48	28.49	10.00	5.00	2.00	1.50	2.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	21.10	9.42	8.67	2.83	0.75	0.57	2.64	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	34.56	15.01	7.73	2.27	0.45	0.45	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	24.12	13.47	6.58	1.25	0.31	0.94	2.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	37.40	19.11	5.23	3.76	0.98	0.65	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	33.68	15.39	6.10	2.03	1.45	0.29	0.87	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	35.27	16.14	5.68	5.98	0.60	2.09	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	34.73	24.39	7.02	7.21	4.25	1.11	1.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	38.51	20.26	5.42	9.41	6.85	0.86	1.43	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	30.62	30.62	3.27	2.04	4.90	0.00	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	34.50	21.83	8.45	4.22	3.17	1.41	1.76	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	33.26	16.15	6.33	2.85	0.32	0.95	2.53	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	34.50	18.46	8.78	3.03	0.61	0.91	1.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.92	9.31	6.21	1.55	0.00	0.00	2.59	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	18.60	9.96	11.29	0.66	0.66	0.00	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	14.11	7.95	3.59	1.03	0.77	0.77	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.20	9.97	5.62	1.28	0.51	1.28	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	9.09	8.33	2.27	3.79	2.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	21.51	13.11	5.38	1.68	0.67	1.01	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	39.61	29.95	5.07	6.52	3.38	1.45	1.93	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	36.10	26.29	3.12	4.01	8.47	1.34	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	42.44	24.88	7.32	7.80	5.85	1.46	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	32.40	18.95	7.64	1.53	0.92	1.22	4.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	29.28	3.25	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	37.40	19.53	3.97	1.65	0.66	0.33	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	24.63	9.85	11.49	2.19	2.19	0.00	3.28	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	19.18	8.69	12.30	2.53	1.09	0.00	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	16.73	8.90	9.96	1.78	0.36	0.36	0.00	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	36.99	10.74	3.58	2.39	2.39	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	27.49	15.44	9.62	1.90	2.71	0.68	1.35	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	23.71	18.59	6.73	1.89	1.08	0.81	2.16	0.00
immature langerhans cells, donor1	11904-125F5	4.36	2.66	0.24	0.48	2.18	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	4.75	3.17	0.79	0.79	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	8.61	6.25	3.60	1.32	0.28	3.88	0.95	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	23.41	10.40	3.25	3.58	0.33	0.65	1.30	0.00
kidney, adult, pool1	10017-101C8	9.71	6.71	1.30	1.30	1.50	0.60	0.40	0.10
kidney, fetal, pool1	10045-101F9	11.88	10.75	2.69	2.76	1.34	0.57	0.42	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	11.22	5.11	3.55	1.28	0.99	0.71	0.71	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.60	4.84	1.94	1.24	0.14	0.97	0.69	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	9.54	4.40	1.65	0.92	2.02	0.37	1.28	0.00
left atrium, adult, donor1	10079-102A7	8.17	1.09	1.63	1.63	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	8.60	2.02	1.52	2.53	0.00	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	38.85	9.58	9.30	5.75	1.37	1.09	2.46	0.00
leiomyoma cell line:10964C	10569-108B2	5.39	3.23	1.44	1.08	1.44	1.44	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	2.17	0.54	0.54	0.54	0.00	1.09	0.00	0.00
leiomyoma cell line:15425	10571-108B4	5.83	4.86	1.21	0.49	0.24	0.97	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	9.41	2.09	2.09	2.09	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	16.29	8.26	2.95	4.13	1.65	3.19	1.30	0.00
liposarcoma cell line:KMLS-1	10782-110G8	6.40	2.19	0.47	1.09	0.62	0.78	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	14.38	4.51	5.73	2.31	0.49	1.22	1.95	0.12
liver, adult, pool1	10018-101C9	5.83	4.70	0.49	0.65	1.30	0.97	0.16	0.00
liver, fetal, pool1	10086-102B5	23.52	4.70	0.94	3.76	2.82	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	11.37	4.81	1.75	2.48	1.17	2.62	0.73	0.73
locus coeruleus, adult, donor10252	10165-103B3	11.81	11.44	3.51	3.51	1.66	1.85	0.74	0.92
locus coeruleus, adult, donor10258	10375-105G6	21.16	7.05	2.82	3.10	0.28	1.13	0.85	0.85
locus coeruleus, newborn, donor10223	10362-105F2	16.82	4.21	2.10	0.42	1.26	0.84	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	4.57	3.32	0.83	0.83	0.00	0.14	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	14.48	2.76	2.76	0.69	0.69	0.00	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	4.22	1.98	2.11	0.53	0.53	1.19	0.66	0.26
lung, adult, pool1	10019-101D1	7.68	7.32	1.06	0.83	1.18	0.47	0.47	0.00
lung, fetal, donor1	10068-101I5	13.13	2.00	1.14	0.86	2.28	0.00	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	15.12	8.25	1.37	3.67	1.83	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	12.78	2.37	0.95	2.84	0.95	0.95	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	21.48	8.99	0.44	1.53	1.75	0.88	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	20.68	4.68	0.91	1.51	1.21	1.21	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.04	5.10	0.85	0.00	3.40	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	3.55	7.99	0.44	1.78	4.00	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	1.25	3.53	0.21	1.25	1.25	0.42	0.42	0.00
mature adipocyte, donor3	12233-129G1	4.03	3.32	0.71	0.47	1.66	0.00	0.24	0.00
mature adipocyte, donor4	12234-129G2	6.58	2.37	1.05	1.05	1.84	0.53	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	18.11	5.72	4.05	1.19	0.95	1.43	0.95	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	11.28	1.13	2.26	0.00	0.00	7.90	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	5.89	5.52	0.92	4.23	0.74	2.76	1.47	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	13.03	4.77	2.22	0.95	0.32	5.72	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	3.84	5.54	1.71	0.00	1.28	3.84	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	7.59	3.88	1.01	1.18	0.34	4.39	0.68	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	11.88	6.37	2.33	3.61	0.64	4.67	1.27	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	3.85	3.85	1.93	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	143.54	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	8.26	6.82	8.26	1.44	1.08	6.46	2.87	0.36
medulla oblongata - adult, donor10196	10174-103C3	11.03	1.95	2.60	0.00	1.30	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	9.13	7.43	2.01	2.94	1.86	1.39	0.62	1.08
medulla oblongata, adult, pool1	10038-101F2	10.69	9.47	1.71	1.55	0.82	1.22	0.49	0.33
medulla oblongata, newborn, donor10223	10361-105F1	15.97	13.89	1.74	2.78	0.69	1.74	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	26.35	19.26	3.76	2.21	1.77	0.66	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	9.17	2.93	3.30	1.47	0.61	0.86	0.24	0.00
melanoma cell line:COLO 679	10514-107E1	4.46	3.31	0.72	0.14	0.29	0.14	0.14	0.00
melanoma cell line:G-361	10465-106H6	12.22	8.96	2.17	1.90	0.00	1.09	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	6.33	4.70	1.27	1.81	0.90	0.18	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	51.99	29.96	6.17	2.64	7.05	1.76	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	39.66	25.92	4.67	4.15	2.59	0.78	2.33	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	7.67	5.52	1.38	1.07	0.31	0.31	1.07	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	2.18	2.36	1.45	0.73	0.00	0.55	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	1.66	1.24	0.41	0.00	0.41	0.41	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	3.09	3.65	1.40	0.42	0.70	0.84	1.12	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	3.08	4.24	0.77	0.19	0.58	0.96	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	7.63	3.47	1.39	0.69	0.00	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	1.20	1.37	0.34	0.34	0.51	0.17	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	4.49	3.34	0.58	0.69	0.69	0.35	0.23	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	5.97	3.98	1.33	0.66	0.80	0.13	0.40	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	4.86	3.11	2.03	0.14	0.95	0.00	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	3.13	3.56	0.71	0.71	0.14	0.57	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	1.98	3.29	0.00	0.66	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	3.18	3.60	1.11	0.14	0.97	0.14	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	9.08	6.28	1.40	0.00	0.00	0.70	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	2.04	2.25	0.82	0.41	0.82	0.41	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	5.39	3.24	1.80	0.72	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	2.59	2.79	1.14	0.62	0.52	0.21	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	2.28	1.14	0.46	0.68	0.46	0.46	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	2.10	1.68	0.00	0.00	1.26	0.42	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	2.99	2.54	1.05	0.30	0.30	0.30	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	2.36	2.10	0.35	0.35	0.26	0.35	0.44	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	8.47	5.89	1.84	2.21	0.37	0.74	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.58	2.58	0.00	0.86	0.00	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	30.73	15.16	2.11	2.95	0.42	1.26	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	11.87	4.57	1.37	0.91	0.91	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.21	7.42	0.26	1.53	0.77	1.02	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.81	3.66	0.79	0.79	0.79	0.52	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.39	6.16	0.92	1.23	1.54	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.83	4.94	0.94	1.41	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.42	4.74	0.34	0.34	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.65	6.68	1.57	0.79	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.49	4.17	0.00	0.93	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.94	5.48	1.44	1.73	0.87	0.58	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.47	6.92	1.12	1.12	1.56	0.00	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	5.77	3.36	0.72	1.44	0.72	0.48	0.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	4.40	0.73	1.47	1.47	1.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	4.36	4.70	0.67	0.67	0.67	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	6.96	4.91	1.23	0.41	0.41	0.00	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5.58	2.58	2.15	0.43	0.86	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	2.73	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.39	4.55	0.97	1.95	0.97	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	14.55	5.82	0.00	0.00	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.46	9.06	0.53	5.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	0.82	0.82	2.45	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	9.72	3.89	2.72	1.55	0.39	0.78	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	4.20	0.00	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	12.92	4.97	0.00	0.00	1.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.71	1.78	0.00	2.37	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	4.87	1.22	2.44	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.30	5.07	1.27	0.63	1.27	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.45	3.45	0.69	1.38	0.34	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	6.45	2.15	0.00	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	7.98	0.00	3.99	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.96	8.56	0.41	2.04	0.00	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.97	7.94	0.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	10.02	0.00	2.36	0.59	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.73	7.48	1.25	2.81	0.00	1.56	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	8.02	1.34	2.67	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	9.46	3.55	4.73	2.37	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	5.14	2.57	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.88	11.70	2.75	2.07	1.38	0.00	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.92	9.90	0.99	1.98	3.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	12.34	3.36	3.36	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	7.00	2.54	4.45	4.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.48	10.88	0.81	3.22	4.43	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	17.44	0.00	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	7.60	1.27	2.53	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	4.86	3.64	1.21	3.03	1.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	13.56	0.00	4.52	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.06	8.24	0.82	3.29	1.65	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	19.05	9.33	1.59	4.76	0.79	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	24.99	9.41	2.27	2.60	2.60	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	10.19	4.07	2.04	0.00	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	6.19	2.32	1.55	1.55	0.77	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	18.43	6.14	1.18	3.07	0.00	0.24	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	4.40	2.55	0.00	2.09	0.93	0.23	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	12.82	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	12.84	7.91	0.62	1.13	1.54	0.21	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	7.94	4.09	1.13	1.13	0.00	1.82	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	11.49	6.11	1.22	0.24	0.49	0.49	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	5.54	3.54	2.44	0.22	0.22	0.44	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	6.31	6.57	2.10	0.79	0.00	0.79	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	12.94	8.00	1.70	1.02	2.04	1.19	0.68	0.17
mesothelioma cell line:Mero-84	10855-111F9	14.16	7.33	1.52	0.51	0.76	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	9.52	5.80	2.90	1.66	0.62	1.45	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	8.28	5.80	3.15	0.83	0.83	0.33	0.66	0.00
mesothelioma cell line:NCI-H226	10846-111E9	9.41	9.41	1.99	1.09	0.72	0.90	0.54	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	9.74	7.69	1.20	0.68	1.20	0.85	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	7.89	7.89	1.53	1.27	0.51	1.27	0.51	0.00
mesothelioma cell line:No36	10857-111G2	13.37	9.79	3.91	1.30	1.30	0.98	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	2.17	1.90	0.81	0.27	0.00	0.81	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	17.46	4.03	0.19	0.96	1.15	0.38	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	12.46	1.59	0.61	0.49	2.20	0.85	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	6.46	3.05	0.36	0.54	0.54	0.54	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	7.18	8.81	0.98	1.63	0.65	0.33	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.74	4.45	2.76	1.91	0.64	0.21	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	5.99	2.07	0.69	1.61	1.61	0.46	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.26	15.22	0.76	4.19	3.81	0.57	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	61.17	22.18	0.74	7.95	5.36	0.37	0.37	0.00
myeloma cell line:PCM6	10474-106I6	40.32	14.23	0.99	3.56	0.79	0.20	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.22	3.55	0.00	2.54	0.51	1.01	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	11.38	8.04	1.18	1.18	2.94	0.78	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.25	5.79	0.33	1.23	1.23	0.89	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.96	3.90	0.51	0.88	1.62	0.66	0.15	0.00
nasal epithelial cells, donor2	12227-129F4	14.90	11.59	1.10	1.10	0.55	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	30.14	9.43	6.67	2.76	1.15	1.15	1.15	0.00
neuroblastoma cell line:NB-1	10539-107G8	76.14	38.35	9.35	9.73	5.43	3.74	2.62	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	7.59	6.75	1.27	0.42	0.21	0.42	0.84	0.00
neuroblastoma cell line:NH-12	10555-107I6	31.31	21.62	4.47	5.40	4.10	0.19	2.05	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	16.13	5.69	0.95	2.37	1.42	0.24	0.95	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	31.99	12.20	6.34	3.48	2.53	0.63	1.74	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	25.16	10.47	2.21	1.81	1.61	0.20	1.41	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.15	5.72	5.09	2.54	1.27	0.00	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	16.77	3.99	1.33	2.13	0.53	0.53	0.53	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	13.36	18.43	4.23	1.35	0.51	0.00	1.35	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	9.61	7.20	4.80	0.80	0.00	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	6.41	4.81	0.64	1.60	0.32	0.00	1.60	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	6.04	6.57	0.26	0.26	0.26	0.00	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	6.47	7.50	3.00	1.22	0.47	4.03	0.84	0.28
occipital cortex - adult, donor10196	10172-103C1	12.36	0.00	4.12	2.06	2.06	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	11.27	11.27	4.29	5.37	1.07	5.10	1.07	0.27
occipital cortex, newborn, donor10223	10355-105E4	13.47	10.55	5.82	1.09	1.09	7.28	2.55	0.36
occipital lobe, adult, donor1	10076-102A4	18.89	5.25	3.94	1.05	0.52	4.20	2.62	0.79
occipital lobe, fetal, donor1	10073-102A1	34.33	13.30	12.01	5.15	0.86	6.44	7.29	0.43
occipital pole, adult, pool1	10036-101E9	7.73	9.07	3.94	1.10	0.47	5.20	1.66	0.32
olfactory region, adult	10195-103E6	8.22	2.87	1.91	1.72	0.96	3.25	0.96	0.00
optic nerve, donor1	10277-104E7	34.02	6.00	2.00	6.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	9.34	12.42	0.57	2.05	1.82	2.62	0.34	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	12.50	4.53	0.55	1.24	1.37	0.55	0.41	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	9.99	6.43	0.51	2.20	0.68	0.17	0.34	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	8.89	6.35	0.69	0.58	1.50	0.58	0.23	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	9.70	7.35	1.18	2.65	1.18	1.47	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	13.08	6.54	1.87	6.54	3.74	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	26.30	18.87	2.54	2.97	2.76	0.85	1.06	0.21
ovary, adult, pool1	10020-101D2	7.95	7.51	2.62	2.01	1.22	0.52	0.61	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.97	6.97	1.65	2.93	0.55	0.00	0.37	0.18
pancreas, adult, donor1	10049-101G4	16.93	7.53	1.88	2.82	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	17.61	8.95	2.52	1.40	3.63	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	6.64	3.41	0.68	0.85	0.17	0.51	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	7.95	2.32	1.49	0.66	0.66	0.66	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	7.69	7.96	4.39	0.92	0.55	4.21	1.46	0.46
parietal cortex, adult, donor10258	10373-105G4	8.81	5.14	2.20	1.47	0.00	2.20	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	11.29	6.58	0.94	0.00	0.94	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	9.69	8.55	3.14	3.71	0.00	3.99	1.14	0.00
parietal lobe, adult, pool1	10034-101E7	6.52	8.64	2.82	1.23	0.79	5.29	1.59	0.62
parietal lobe, fetal, donor1	10072-101I9	38.79	13.58	12.61	1.94	2.91	2.91	4.85	1.94
parietal lobe, newborn, donor10223	10356-105E5	8.22	6.73	3.36	0.75	0.75	3.36	0.75	0.00
parotid gland, adult	10199-103F1	4.93	6.78	0.62	1.23	1.85	0.00	0.00	0.00
penis, adult	10200-103F2	6.98	3.76	1.61	1.61	2.15	0.00	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	11.71	9.11	1.12	1.49	3.53	0.19	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	15.44	5.68	3.93	1.89	0.87	1.60	0.73	0.00
pineal gland - adult, donor10196	10179-103C8	2.58	1.94	0.65	3.23	0.00	1.29	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	6.51	2.37	0.00	1.78	0.00	1.18	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	4.39	1.25	0.00	0.63	0.00	1.25	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	1.01	1.01	0.00	0.00	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	5.73	7.30	0.52	1.56	1.04	0.52	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	5.96	2.55	0.85	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	5.70	3.23	0.54	1.08	0.86	0.22	0.22	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	11.52	6.49	1.46	0.79	0.93	0.66	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	16.81	5.14	2.80	1.71	0.31	0.16	0.62	0.00
pons, adult, pool1	10033-101E6	7.49	6.80	1.81	0.95	0.95	1.72	0.86	0.43
postcentral gyrus, adult, pool1	10032-101E5	10.11	9.15	3.23	0.96	0.61	3.92	2.27	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	4.18	0.00	2.09	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	16.52	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	33.07	15.73	2.91	3.93	1.31	1.31	1.02	0.00
prostate cancer cell line:PC-3	10439-106E7	25.05	6.72	5.63	5.08	1.45	1.45	0.54	0.54
prostate, adult, pool1	10022-101D4	7.07	7.98	2.09	1.27	1.63	0.18	0.36	0.09
putamen, adult, donor10196	10176-103C5	4.25	5.90	1.18	0.71	0.24	1.42	2.12	0.71
putamen, adult, donor10252	10152-102I8	11.76	5.88	1.96	11.76	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	9.84	3.28	2.19	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	4.83	5.56	3.14	0.00	0.48	3.62	0.48	0.72
putamen, newborn, donor10223	10365-105F5	17.24	8.25	0.00	0.75	0.00	1.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	16.58	2.33	1.16	1.75	2.33	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	36.17	4.17	5.56	6.95	2.78	0.00	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	17.38	5.72	0.85	1.27	0.21	1.48	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	9.94	4.14	0.00	0.41	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	6.06	6.06	1.19	0.60	0.99	0.80	0.50	0.10
retinoblastoma cell line:Y79	10475-106I7	65.47	25.20	3.38	3.64	1.56	1.30	2.86	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	6.39	2.95	1.11	0.61	0.86	0.74	0.61	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	25.03	9.56	2.53	3.66	1.69	1.69	1.69	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.85	2.27	1.52	3.03	1.52	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	6.64	5.83	0.81	0.81	1.46	1.62	0.00	0.00
salivary acinar cells, donor2	11772-123I8	10.46	8.40	1.38	0.41	1.24	1.10	0.55	0.00
salivary acinar cells, donor3	11773-123I9	7.94	3.97	0.66	0.66	2.65	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	5.15	1.72	0.57	0.00	1.14	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	8.43	5.14	0.84	0.59	0.17	0.59	0.51	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	13.87	3.64	0.82	2.47	0.12	1.06	0.47	0.00
seminal vesicle, adult	10201-103F3	12.17	5.29	1.06	2.12	2.65	1.06	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	10.45	4.86	0.97	0.97	0.49	0.24	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	9.31	7.55	2.77	1.26	0.75	1.26	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	23.08	6.02	0.00	1.00	3.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	7.12	5.78	0.67	0.94	0.67	0.27	0.54	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	5.86	4.75	1.55	0.77	0.99	1.33	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	14.97	8.39	1.42	1.16	1.55	0.13	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	4.97	0.00	0.71	0.71	0.71	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	5.76	4.68	1.08	1.68	3.84	0.60	0.60	0.12
skeletal muscle, fetal, donor1	10066-101I3	77.39	10.05	3.02	12.06	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	23.36	4.42	0.63	3.79	1.89	0.00	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	39.36	19.01	4.34	5.00	5.34	1.00	1.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	41.61	20.17	5.67	3.47	2.21	1.58	2.52	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	21.20	12.53	17.54	3.08	0.96	1.16	5.01	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	21.26	9.72	1.15	1.32	1.48	0.66	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	20.59	9.01	2.25	1.77	1.29	0.32	0.32	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	8.93	9.15	3.05	0.44	1.96	1.74	0.65	0.00
small intestine, adult, pool1	10024-101D6	22.93	11.82	0.72	2.75	3.82	0.96	0.48	0.00
small intestine, fetal, donor1	10064-101I1	14.99	3.44	2.95	1.97	0.25	0.25	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.75	8.21	1.54	2.05	2.05	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	5.17	3.36	2.07	4.14	0.26	0.00	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	11.52	2.41	0.54	1.07	0.54	1.07	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	15.37	4.82	2.06	5.51	0.69	0.69	0.00	0.46
spinal cord, adult, donor10252	10159-103A6	18.53	10.25	3.15	4.34	1.58	1.58	1.97	0.00
spinal cord, adult, donor10258	10369-105F9	15.91	6.23	2.08	2.08	0.00	1.38	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	54.28	11.59	7.93	4.88	3.05	2.44	3.66	1.22
spinal cord, newborn, donor10223	10359-105E8	16.53	12.40	0.46	1.38	1.84	0.92	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	12.40	6.87	0.90	1.94	1.05	0.75	0.30	0.30
spleen, adult, pool1	10025-101D7	9.80	9.91	1.10	2.31	1.54	0.44	0.55	0.11
spleen, fetal, pool1	10044-101F8	14.86	21.21	2.70	3.10	3.10	0.64	0.87	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.32	10.66	1.86	0.93	0.52	0.72	0.41	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	16.71	4.56	0.38	1.33	1.90	0.19	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	10.83	3.15	2.45	3.15	1.05	1.05	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	2.74	0.78	0.78	0.78	0.39	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	17.11	9.23	0.79	2.59	1.24	0.45	0.79	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	58.88	16.94	14.83	2.54	2.54	1.27	3.39	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	10.15	3.38	1.27	2.96	1.27	0.85	0.85	0.00
stomach, fetal, donor1	10062-101H8	12.82	1.07	0.00	3.20	1.07	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	5.13	2.85	1.71	0.57	0.00	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	13.29	14.12	3.32	2.28	1.87	0.00	1.45	0.62
substantia nigra, adult, donor10258	10371-105G2	6.21	7.24	0.52	2.07	0.52	2.59	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	14.13	6.36	4.24	0.00	2.83	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	70.38	21.55	6.19	8.25	1.83	1.60	1.15	0.23
temporal lobe, adult, pool1	10031-101E4	10.68	11.19	3.98	1.44	0.42	5.43	2.12	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	42.02	7.12	9.97	5.70	0.71	4.99	7.12	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	16.70	6.59	7.47	1.32	0.00	3.52	1.76	0.00
tenocyte, donor1	11763-123H8	7.33	7.33	1.75	1.75	0.70	0.70	1.05	0.00
tenocyte, donor2	11765-123I1	5.72	6.87	0.76	1.53	0.38	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	7.78	4.45	0.00	0.74	1.11	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	21.75	13.26	5.10	2.55	4.42	0.34	0.68	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	58.42	26.67	4.16	6.63	2.16	1.08	1.85	0.31
teratocarcinoma cell line:PA-1	10807-111A6	19.99	9.76	3.56	4.03	2.32	0.15	0.77	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	10.92	6.35	1.78	2.41	4.44	1.40	0.89	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	2.65	3.03	1.13	1.51	3.03	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	4.14	2.29	2.18	0.33	6.22	0.87	0.98	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	5.21	6.84	2.93	1.30	6.84	0.98	0.65	0.00
testis, adult, pool1	10026-101D8	9.77	9.66	1.50	2.47	3.33	0.54	0.97	0.00
testis, adult, pool2	10096-102C6	6.32	4.96	3.61	2.71	2.26	0.90	0.45	0.45
thalamus - adult, donor10196	10168-103B6	9.94	3.31	3.31	1.10	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	11.56	11.56	2.19	5.47	1.72	1.41	0.94	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	1.54	7.70	0.00	3.08	1.54	3.08	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.30	4.12	1.32	2.80	0.82	0.99	0.33	0.49
thalamus, newborn, donor10223	10366-105F6	14.96	2.88	2.88	0.58	0.00	0.00	0.58	0.58
throat, adult	10209-103G2	6.24	6.74	1.50	0.25	2.00	0.25	0.25	0.00
throat, fetal, donor1	10061-101H7	17.06	6.40	1.83	3.66	1.52	0.30	0.91	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	24.64	13.51	2.38	2.19	0.40	1.59	0.99	0.00
thymus, adult, pool1	10027-101D9	55.18	54.08	9.54	8.65	4.27	0.60	3.28	0.20
thymus, fetal, pool1	10043-101F7	30.76	34.39	6.34	5.09	2.81	0.52	1.45	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	12.63	6.12	1.86	1.46	0.66	0.13	0.66	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	21.79	13.55	3.49	2.51	1.12	1.82	0.84	0.00
thyroid, adult, pool1	10028-101E1	9.80	10.17	1.87	2.24	1.77	0.65	0.47	0.09
thyroid, fetal, donor1	10060-101H6	13.18	3.69	0.79	4.22	0.79	0.00	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	3.08	3.08	9.24	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	6.05	4.42	0.70	1.40	2.09	0.70	0.23	0.00
tongue, fetal, donor1	10059-101H5	31.13	9.06	2.36	6.70	1.58	1.18	2.36	0.00
tonsil, adult, pool1	10047-101G2	8.62	8.41	0.80	2.10	1.90	0.40	0.20	0.00
trachea, adult, pool1	10029-101E2	7.93	6.95	1.80	1.23	0.98	0.57	0.65	0.08
trachea, fetal, donor1	10058-101H4	21.54	3.08	0.77	5.77	1.92	1.15	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	8.15	4.25	1.77	1.77	0.00	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	9.93	4.46	1.32	1.11	1.22	0.61	0.20	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	24.13	15.04	0.94	1.72	1.72	0.63	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	9.51	1.90	0.00	5.71	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	6.43	3.47	2.37	1.27	0.34	0.34	0.68	0.00
umbilical cord, fetal, donor1	10057-101H3	6.26	2.09	0.00	8.35	2.09	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	5.46	2.56	1.71	1.54	0.85	0.34	1.19	0.00
uterus, fetal, donor1	10055-101H1	46.59	5.63	6.14	6.66	1.54	0.00	1.54	0.00
vagina, adult	10204-103F6	4.52	9.69	4.52	7.75	1.29	2.58	0.00	0.65
vein, adult	10191-103E2	13.37	7.23	0.88	1.53	1.32	0.88	1.32	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.01	4.81	0.80	1.07	0.53	0.00	0.27	0.00